( (TITLE (S (NP-SBJ (NML (NN GABAA) (NN receptor)) (NML (NML (NN γ2) (NN subunit)) (NN knockdown)) (NNS mice)) (VP (VBP have) (NP (NP (VBN enhanced) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NN behavior)) (CC but) (NP (NP (JJ unaltered) (JJ hypnotic) (NN response)) (PP (IN to) (NP (NNS benzodiazepines)))))))) )
( (HEADING (NP (NN Abstract))) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ-1 (NP (NML (ADJP (NN Gamma) (HYPH -) (JJ aminobutyric)) (NN acid)) (NML (NN type) (NN A)) (NNS receptors)) (-LRB- -LRB-) (NP (NN GABAA) (HYPH -) (NNS Rs))) (-RRB- -RRB-) (VP (VP (VBP are) (NP-PRD (DT the) (JJ major) (JJ inhibitory) (NNS receptors)) (PP-LOC (IN in) (NP (DT the) (JJ mammalian) (NN brain)))) (CC and) (VP (VBP are) (VP (VBN modulated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN number)) (PP (IN of) (NP (ADJP (JJ sedative) (HYPH /) (JJ hypnotic)) (NNS drugs))) (PP (VBG including) (NP (NNS benzodiazepines) (CC and) (NNS anesthetics)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN significance)) (PP (IN of) (NP (JJ specific) (NML (NN GABAA) (HYPH -) (NNS Rs)) (NNS subunits))) (PP (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (NP (NN behavior)) (CC and) (NP (ADJP (FW in) (FW vivo)) (NN drug) (NNS responses))))))) (VP (VBZ is) (ADVP (RB incompletely)) (VP (VBN understood) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (DT The) (NN γ2) (NN subunit)) (VP (VBZ is) (ADJP-PRD (RB highly) (VBN expressed)) (PP-LOC (IN throughout) (NP (DT the) (NN brain)))) (. .)) )
( (S (NP-SBJ (JJ Global) (NML (NN γ2) (NN knockout)) (NNS mice)) (VP (VP (VBP are) (ADJP-PRD (JJ insensitive) (PP (IN to) (NP (NP (DT the) (JJ hypnotic) (NNS effects)) (PP (IN of) (NP (NN diazepam))))))) (CC and) (VP (VBP die) (ADVP-TMP (RB perinatally)))) (. .)) )
( (S (NP-SBJ (JJ Heterozygous) (NML (NN γ2) (JJ global) (NN knockout)) (NNS mice)) (VP (VP (VBP are) (ADJP-PRD (JJ viable))) (CC and) (VP (VBP have) (NP (VBN increased) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NNS behaviors)))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (ADVP (RB further)) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT the) (NN γ2) (NN subunit))) (PP (IN in) (NP (NP (NN behavior)) (CC and) (NP (NML (JJ whole) (NN animal)) (NN drug) (NN action)))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD used) (NP (NN gene) (NN targeting)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NP (NP (DT a) (JJ novel) (NN mouse) (NN line)) (PP (IN with) (NP (VBN attenuated) (NN γ2) (NN expression)))) (, ,) (NP (ADVP (FW i.e.)) (, ,) (NP (NML (NN γ2) (NN knockdown)) (NNS mice)))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (S (NP-SBJ-1 (NN Knockdown) (NNS mice)) (VP (VBD were) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG inserting) (NP (DT a) (NML (NN neomycin) (NN resistance)) (NN cassette)) (PP-DIR (IN into) (NP (NP (NN intron) (CD 8)) (PP (IN of) (NP (DT the) (NN γ2) (NN gene)))))))))) (. .)) )
( (S (S (NP-SBJ (NN Knockdown) (NNS mice)) (, ,) (PP (IN on) (ADJP (JJ average))) (, ,) (VP (VBD showed) (NP (NP (DT a) (NML (CD 65) (NN %)) (NN reduction)) (PP (IN of) (NP (NN γ2) (NN subunit) (NN mRNA)))) (PP (VBN compared) (PP (IN to) (NP (NNS controls)))))) (: ;) (S (ADVP (RB however)) (NP-SBJ (NN γ2) (NN gene) (NN expression)) (VP (VBD was) (ADJP-PRD (RB highly) (JJ variable)) (PP-LOC (IN in) (NP (DT these) (NNS mice))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG ranging) (PP (PP (IN from) (NP (NP (CD 10) (NML-1 (-NONE- *RNR*))) (PP-2 (-NONE- *RNR*)))) (PP (SYM –) (NP (NP (CD 95) (NML-1 (-NONE- *RNR*))) (PP-2 (-NONE- *RNR*)))) (NML-1 (NN %)) (PP-2 (IN of) (NP (JJ normal)))))))) (. .)) )
( (S (NP-SBJ (JJ Immunohistochemical) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-1 (NN γ2) (NN protein) (NNS levels)) (VP (VBD were) (ADVP (RB also)) (ADVP (RB variably)) (VP (VBN reduced) (NP-1 (-NONE- *))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Pharmacological) (NNS studies)) (VP (VBG using) (NP (NN autoradiography)) (PP-LOC (IN on) (NP (VBN frozen) (NN brain) (NNS sections))))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-1 (NP (NN binding)) (PP (IN of) (NP (NP (DT the) (NN benzodiazepine) (NN site) (NN ligand)) (NP (NN Ro15) (HYPH -) (CD 4513))))) (VP (VBD was) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN mutant) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NNS controls))))))))) (. .)) )
( (S (ADVP (RB Behaviorally)) (, ,) (NP-SBJ (NN knockdown) (NNS mice)) (VP (VBD displayed) (NP (VBN enhanced) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NNS behaviors)) (PP (IN on) (NP (DT the) (NML (NML (VBN elevated) (CC plus) (NN maze)) (CC and) (NML (NML (VBN forced) (NN novelty)) (NN exploration))) (NNS tests)))) (. .)) )
( (S (ADVP (RB Surprisingly)) (, ,) (NP-SBJ (NN mutant) (NNS mice)) (VP (VBD had) (NP (NP (DT an) (JJ unaltered) (NN response)) (PP (IN to) (NP (NP (JJ hypnotic) (NNS doses)) (PP (IN of) (NP (NP (NP (DT the) (NN benzodiazepine) (NN site) (NNS ligands)) (NP (NN diazepam) (, ,) (NN midazolam) (CC and) (NN zolpidem))) (CONJP (RB as) (RB well) (IN as)) (NP (NN ethanol) (CC and) (NN pentobarbital)))))))) (. .)) )
( (S (ADVP (RB Lastly)) (, ,) (NP-SBJ (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (NML (NN γ2) (NN knockdown)) (NN mouse) (NN line)) (VP (MD can) (VP (VB be) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NML (NN γ2) (JJ global) (NN knockout)) (NNS mice))))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (PP (IN to) (NP (DT a) (JJ general) (NN deleter) (ADJP (NN cre) (HYPH -) (VBG expressing)) (NN mouse) (NN line)))))))))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (NP-SBJ (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (: :) (S (LST (LS 1) (-RRB- -RRB-)) (NP-SBJ (NP (NN insertion)) (PP (IN of) (NP (DT a) (NN neomycin) (NN resistance) (NN gene))) (PP (IN into) (NP (NP (NN intron) (CD 8)) (PP (IN of) (NP (DT the) (NN γ2) (NN gene)))))) (ADVP (RB variably)) (VP (VBD reduced) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN γ2))))))) (, ,) (CC and) (SBAR (IN that) (S (LST (LS 2) (-RRB- -RRB-)) (NP-SBJ (NP (VBN attenuated) (NN expression)) (PP (IN of) (NP (NN γ2)))) (VP (VP (VBD increased) (NP (ADJP (NN anxiety) (HYPH -) (JJ like)) (NNS behaviors))) (CC but) (VP (VBD did) (RB not) (VP (VB lead) (PP (IN to) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (DT the) (JJ hypnotic) (NN response)) (PP (IN to) (NP (NN benzodiazepine) (NN site) (NNS ligands)))))))))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (VBN reduced) (JJ synaptic) (NN inhibition)) (VP (MD can) (VP (VB lead) (PP (IN to) (NP (NP (DT a) (NN phenotype)) (PP (IN of) (NP (VBN increased) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NN behavior)))))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (JJ normal) (NN drug) (NNS effects)) (VP (MD can) (VP (VB be) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP (IN despite) (NP (NP (DT a) (JJ dramatic) (NN reduction)) (PP (IN in) (NP (NML (NN GABAA) (HYPH -) (NN R)) (NNS targets)))))))) (. .)) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ-1 (NN GABAA) (HYPH -) (NNS Rs)) (VP (VP (VBP are) (NP-PRD (DT the) (JJ major) (JJ inhibitory) (NNS receptors)) (PP-LOC (IN in) (NP (DT the) (JJ mammalian) (JJ central) (JJ nervous) (NN system)))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN modulated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN number)) (PP (IN of) (NP (ADJP (JJ sedative) (, ,) (JJ hypnotic) (CC and) (JJ anesthetic)) (NNS drugs))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])))))) (. .)) )
( (S (NP-SBJ (NN GABAA) (HYPH -) (NNS Rs)) (VP (VP (VBP are) (NP-PRD (ADJP (RB putatively) (JJ pentameric)) (NNS complexes))) (CC and) (VP (VBP are) (NP-PRD (NP (NNS members)) (PP (IN of) (NP (NP (DT a) (`` ') (NN superfamily)) ('' ') (PP (IN of) (NP (VBN related) (ADJP (NN ligand) (HYPH -) (VBN gated)) (NN ion) (NNS channels)))))))) (. .)) )
( (S (S (NP-SBJ (EX There)) (VP (VBP are) (NP-PRD (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NN subunit) (NNS families)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP make) (PRT (RP up)) (NP (NN GABAA) (HYPH -) (NNS Rs)))))))))) (, ;) (S (NP-SBJ-3 (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD seventeen) (JJ distinct) (NNS subunits)) (NP-2 (-NONE- *ICH*))))) (VP (VBP have) (VP (VBN been) (VP (VBN cloned) (NP-3 (-NONE- *)) (, ,) (NP-2 (NP (NP (NN α1)) (PP (HYPH –) (NP (CD 6)))) (, ,) (NP (NP (NN β1)) (PP (SYM –) (NP (CD 4)))) (, ,) (NP (NP (NN γ1)) (PP (SYM –) (NP (CD 3)))) (, ,) (NP (NN δ)) (, ,) (NP (NN ε)) (, ,) (NP (NN π)) (, ,) (CC and) (NP (NN θ))))))) (. .)) )
( (S (S (NP-SBJ-1 (NP (RB Much)) (PP-4 (-NONE- *ICH*))) (VP (VBZ is) (VP (VBN known) (NP-1 (-NONE- *)) (PP-4 (IN of) (NP (NP (DT the) (NNS subunits)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP comprise) (NP (NN GABAA) (HYPH -) (NNS Rs)))))))))) (, ,) (CC but) (S (NP-SBJ-3 (NP (DT the) (NN contribution)) (PP (IN of) (NP (JJ individual) (NNS subunits))) (PP (IN to) (NP (ADJP (FW in) (FW vivo)) (NN drug) (NNS responses)))) (VP (VBZ is) (RB only) (VP (VBG beginning) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN understood) (NP-3 (-NONE- *)) (, ,) (PP-MNR (ADVP (RB largely)) (IN through) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (ADJP (RB genetically) (VBN engineered)) (NNS mice))))) (PRN (-LRB- [) (NP (NP (CD 2)) (PP (SYM -) (NP (CD 4)))) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN γ2) (NN subunit)) (VP (VP (VBZ is) (ADVP (RB highly)) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN throughout) (NP (ADJP (VBG developing) (CC and) (JJ adult)) (NML (NML (NN brain)) (CC and) (NML (JJ spinal) (NN cord))))))) (, ,) (VP (VBZ is) (NP-PRD (NP (DT a) (NN component)) (PP (IN of) (NP (NP (QP (RB almost) (CD 60)) (NN %)) (PP (IN of) (NP (DT all) (NN GABAA) (HYPH -) (NNS Rs)))))) (PRN (-LRB- [) (NP (CD 5) (, ,) (CD 6)) (-RRB- ]))) (, ,) (CC and) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (JJ synaptic) (NN clustering)) (PP (IN of) (NP (NN GABAA) (HYPH -) (NNS Rs))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (ADJP (FW In) (FW vitro)) (JJ electrophysiologic) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT an) (JJ obligatory) (NN role)) (PP (IN of) (NP (DT the) (NN γ2) (NN subunit))) (PP (IN for) (NP (NN benzodiazepine) (NN responsiveness)))) (PRN (-LRB- [) (NP (CD 8)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (NNP Gunther)) (ADVP-ETC (FW et) (FW al.))) (VP (VBD created) (CC and) (VBD studied) (NP (NP (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB globally)) (VP (VBD lacked) (NP (NP (DT all) (NN γ2) (NNS subunits)) (PP (IN of) (NP (DT the) (NN GABAA) (HYPH -) (NN R)))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Mice)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (NN γ2) (NN knockout))))) (VP (VBD died) (PP-TMP (IN in) (NP (DT the) (JJ perinatal) (NN period))) (PP (IN with) (S-NOM (NP-SBJ (JJ rare) (NNS survivors)) (VP (VBG reaching) (NP (JJ postnatal) (NN day) (CD 18)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Knockouts)) (VP (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ normal))) (PP-TMP (IN at) (NP (NN birth)))) (, ,) (CC but) (VP (VBD developed) (NP (NP (NN sensorimotor) (NNS abnormalities)) (VP (VBN characterized) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN hyperactivity)) (, ,) (NP (VBN impaired) (NML (NN grasping) (CC and) (NN righting)) (NN reflex)) (, ,) (CC and) (NP (JJ abnormal) (NN gait)))))))) (. .)) )
( (S (ADVP (RB Pharmacologically)) (, ,) (NP-SBJ (NP (NN knockout)) (PP (IN of) (NP (NN γ2)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ severe) (NN deficit)) (PP (IN in) (NP (NN benzodiazepine) (NN binding) (NNS sites))) (PRN (-LRB- -LRB-) (NP (NP (NML (QP (SYM ~) (CD 94)) (NN %)) (NN reduction)) (PP (VBN compared) (PP (IN to) (NP (NN control))))) (-RRB- -RRB-)))) (SBAR-ADV (IN while) (S (NP-SBJ-1 (NN GABA) (NN binding) (NNS sites)) (VP (VBD were) (ADVP (RB only) (RB slightly)) (VP (VBN reduced) (NP-1 (-NONE- *))))))) (. .)) )
( (S (ADVP (RB Behaviorally)) (, ,) (PP-LOC (IN in) (NP (NP (DT the) (JJ few) (NNS mice)) (SBAR (WHNP-4 (WDT that)) (S (NP-SBJ-4 (-NONE- *T*)) (VP (VBD survived) (ADVP-TMP (RB long) (RB enough) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB be) (VP (VBN tested) (NP-1 (-NONE- *)))))))))))) (, ,) (NP-SBJ-3 (NN diazepam)) (VP (VBD failed) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB induce) (NP (NP (NN sedation)) (CC and) (NP (NP (NN loss)) (PP (IN of) (NP (DT the) (NN righting) (NN reflex))))) (PP (IN at) (NP (NP (NNS doses)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (RB fully) (JJ effective)) (PP-LOC (IN in) (NP (NML (JJ wild) (NN type)) (NNS mice))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))))))))))) (. .)) )
( (S (NP-SBJ (NML (NN γ2) (JJ heterozygous) (NN knockout)) (NNS mice)) (VP (VP (VBD were) (ADVP (RB normally)) (ADJP-PRD (JJ viable))) (, ,) (VP (VBD had) (NP (NP (DT a) (NML (QP (SYM ~) (CD 50)) (NN %)) (NN reduction)) (PP (IN in) (NP (NML (NN γ2) (NN protein)) (NNS levels))))) (, ,) (CC and) (VP (VBD displayed) (NP (VBN increased) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NNS behaviors)) (PRN (-LRB- [) (NP (CD 10)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Drug) (NNS responses)) (PP (IN of) (NP (JJ heterozygous) (NN γ2) (JJ global) (NNS knockouts)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (, ,) (PP (IN except) (PP (IN for) (NP (NP (DT the) (JJ high) (NN efficacy)) (PP (IN of) (NP (NP (JJ low) (NN diazepam) (NNS doses)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB induce) (NP (NN anxiolysis))))))))))) (PRN (-LRB- [) (NP (CD 10)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD set) (PRT (RP out)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB make) (NP (NP (NP (NP (NNS mice)) (PP (IN with) (NP (NP (ADJP (RB markedly) (VBN attenuated)) (NN expression)) (PP (IN of) (NP (DT the) (NN γ2) (NN gene)))))) (-LRB- -LRB-) (NP (ADVP (FW i.e.)) (, ,) (NML (NN γ2) (NN knockdown)) (NNS mice))) (-RRB- -RRB-) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (MD would) (VP (VB be) (ADJP-PRD (ADJP (JJ viable)) (CONJP (CC and) (RB therefore)) (ADJP (JJ useful) (PP (IN for) (NP (NP (NNS studies)) (PP (IN of) (NP (NP (JJ basic) (NNS behaviors)) (CC and) (NP (ADJP (NN drug) (VBN induced)) (NNS responses))))))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD used) (NP (NML (NML (NN gene) (NN targeting)) (CC and) (NML (JJ embryonic) (NN stem) (NN cell))) (NNS technologies)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (DT this) (NN mouse) (NN line)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG inserting) (NP (NP (DT a) (NN neomycin) (NN resistance) (NN gene)) (-LRB- -LRB-) (NP (NN NEO))) (-RRB- -RRB-) (PP-DIR (IN into) (NP (NP (NN intron) (CD 8)) (PP (IN of) (NP (DT the) (NN γ2) (JJ genomic) (NN locus)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Insertion)) (PP (IN of) (NP (NN NEO))) (PP (IN into) (NP (JJ intronic) (NN DNA)))) (VP (VBZ has) (ADVP-TMP (RB previously)) (VP (VBN been) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NP (JJ hypomorphic) (NNS alleles)) (PP (IN of) (NP (JJ several) (NNS genes))))))) (PRN (-LRB- [) (NP (NP (CD 11)) (PP (SYM -) (NP (CD 23)))) (-RRB- ]))))) (. .)) )
( (S (PP (IN In) (NP (DT those) (NNS studies))) (, ,) (NP-SBJ (NP (NN expression)) (PP (IN of) (NP (DT the) (JJ hypomorphic) (NN allele)))) (VP (VBD ranged) (NP (PP (PP (IN from) (NP (NP (CD 5) (NML-1 (-NONE- *RNR*))) (PP-2 (-NONE- *RNR*)))) (PP (SYM –) (NP (NP (CD 25) (NML-1 (-NONE- *RNR*))) (PP-2 (-NONE- *RNR*))))) (NML-1 (NN %)) (PP-2 (IN of) (NP (NN control)))) (: ;) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (ADJP (RB substantially) (JJR lower)) (PP (IN than) (NP (NP (DT the) (NML (CD 50) (NN %)) (NN reduction)) (VP (ADVP (RB typically)) (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (JJ heterozygous) (NNS knockouts))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NML (NN γ2) (NN knockdown)) (NN mouse) (NN line)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (JJ present) (NN report))))) (VP (VBD had) (NP (NP (DT a) (ADJP (RB highly) (JJ variable)) (NN reduction)) (PP (IN in) (NP (NML (NML (NN γ2) (NN mRNA)) (CC and) (NML (NN protein))) (NNS levels))))) (. .)) )
( (S (NP-SBJ (NML (NN γ2) (NN knockdown)) (NNS mice)) (VP (VP (VBD were) (ADJP-PRD (RB normally) (JJ viable))) (, ,) (VP (VBD had) (NP (VBN increased) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NNS behaviors))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN in) (NP (NP (DT the) (JJ hypnotic) (NN response)) (PP (IN to) (NP (NNS benzodiazepines)))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ-1 (NP (NN exon) (CD 8)) (PP (IN of) (NP (DT the) (NN γ2) (NN gene)))) (VP (VBD was) (VP (VBN flanked) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN loxP) (NNS sites))) (PP-LOC (IN in) (NP (DT this) (NN mouse) (NN line))))))) (, ,) (NP-SBJ-2 (DT these) (NNS mice)) (VP (MD could) (ADVP (RB also)) (VP (VB be) (VP (VBN converted) (NP-2 (-NONE- *)) (PP (IN into) (NP (DT a) (NML (JJ global) (NN knockout)) (NN mouse))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (PP (IN to) (NP (DT a) (NML (JJ general) (NN deleter)) (ADJP (NN Cre) (HYPH -) (VBG expressing)) (JJ transgenic) (NN mouse) (NN line))))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NN Production)) (PP (IN of) (NP (ADJP (NN gene) (VBN targeted)) (NNS mice))))) )
( (S (NP-SBJ (QP (CD Four) (IN out) (IN of) (CD 330)) (NML (JJ embryonic) (NN stem) (NN cell)) (NNS clones)) (VP (VBD displayed) (NP (NP (DT the) (VBN predicted) (NML (NN restriction) (NN fragment) (NN length)) (NNS polymorphisms) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (ADJP (JJ indicative) (PP (IN of) (NP (NP (DT the) (NN targeting) (NN event)) (VP (VBN presented) (NP (-NONE- *)) (PP (IN in) (NP (NN Fig) (NN 1A))))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (DT the) (NN targeting) (NN event)) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (NN γ2) (NN locus)) (SBAR (WHPP-2 (IN in) (WHNP (WDT which))) (S (NP-SBJ-1 (NN exon) (CD 8)) (VP (VBZ is) (VP (VBN flanked) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN loxP) (NNS sites))) (PP-LOC-2 (-NONE- *T*))))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP refer) (PP (IN to) (NP (DT this) (NN locus))) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG being) (ADJP-PRD (JJ floxed) (PRN (-LRB- -LRB-) (NP (NN F)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NN contrast)) (PP (IN to) (NP (DT the) (JJ endogenous) (NML (JJ wild) (NN type)) (NN allele) (PRN (-LRB- -LRB-) (NP (SYM +)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (NP (CD Two) (ADJP (RB correctly) (VBN targeted)) (NN cell) (NNS lines)) (, ,) (NP (NN 26L6) (CC and) (NN 26C8))) (VP (VBD yielded) (NP (ADJP (NP (NN germ) (HYPH -) (NN line)) (JJ competent)) (JJ chimeric) (NNS males))) (. .)) )
( (S (NP-SBJ-1 (NNS Chimeras)) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS females))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Offspring)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (NP-PRD (SYM +) (HYPH /) (NN F)))))) (VP (VBD were) (VP (VBN interbred) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (NML (NML (SYM +) (HYPH /) (SYM +)) (, ,) (NML (SYM +) (HYPH /) (NN F)) (, ,) (CC and) (NML (NN F) (HYPH /) (NN F))) (NNS mice))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN genotyped) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (NN weaning))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (SBAR-MNR (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN indicated) (NP-2 (-NONE- *)) (PP (IN in) (NP (NN Fig) (NN 1B)))))))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN analysis))) (, ,) (NP-SBJ (NN Probe) (NN A)) (VP (VBD hybridized) (PP (IN to) (NP (NP (NP (DT a) (NML (CD 9.2) (NN kB)) (NN BglII) (NN fragment)) (PP (IN from) (NP (DT the) (NML (JJ wild) (NN type)) (NN γ2) (NN allele)))) (CC and) (NP (NP (DT a) (NML (CD 3.4) (NN kB)) (NN fragment)) (PP (IN from) (NP (DT the) (VBN targeted) (NN allele))))))) (. .)) )
( (S (PP-TPC-1 (IN Of) (NP (NP (CD 724) (NNS mice)) (VP (VBN genotyped) (NP (-NONE- *))))) (, ,) (S (NP-SBJ (NP (CD 196) (PRN (-LRB- -LRB-) (NP (CD 27) (NN %)) (-RRB- -RRB-))) (PP-1 (-NONE- *T*))) (VP (VBD were) (NP-PRD (SYM +) (HYPH /) (SYM +)))) (, ,) (S (NP-SBJ (CD 372) (PRN (-LRB- -LRB-) (NP (CD 51) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (NP-PRD (SYM +) (HYPH /) (NN F)))) (, ,) (CC and) (S (NP-SBJ (CD 156) (PRN (-LRB- -LRB-) (NP (CD 22) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (NP-PRD (NN F) (HYPH /) (NN F)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS values)) (VP (VBP are) (PP-PRD (IN in) (NP (NP (NN accord)) (PP (IN with) (NP (DT the) (NML (NML (CD 1)) (PP (SYM :) (NP (CD 2))) (PP (SYM :) (NP (CD 1)))) (NN genotype) (NN frequency))))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (JJ Mendelian) (NN genetics))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (JJ homozygous) (JJ floxed) (NNS mice)) (VP (VBD were) (ADJP-PRD (RB normally) (JJ viable))) (. .)) )
( (S (NP-SBJ (PRP They)) (VP (VBD were) (ADVP (RB also)) (ADJP-PRD (ADJP (JJ healthy)) (CC and) (ADJP (RB overtly) (JJ indistinguishable) (PP (IN from) (NP (NML (JJ wild) (NN type)) (NNS mice)))))) (. .)) )
( (HEADING (NP (NML (NNP Northern) (NN blot)) (NN analysis))) )
( (S (NP-SBJ-1 (JJ Semi-quantitative) (NNP northern) (NNS blots)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN γ2) (NN mRNA)))) (PP-LOC (IN in) (NP (NML (NML (JJ wild) (NN type)) (CC and) (NML (NN F) (HYPH /) (NN F))) (NNS animals)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Hybridization)) (PP (IN of) (NP (JJ adult) (NN brain) (NN RNA))) (PP (IN with) (NP (DT a) (NML (NN γ2) (NN cDNA)) (NN probe)))) (VP (VBD yielded) (NP (DT an) (JJ intense) (NML (CD 2.8) (NN kB)) (NN band)) (PP-LOC (IN in) (NP (NML (JJ wild) (NN type)) (NNS mice)))) (. .)) )
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN RNA)) (PP (IN from) (NP (NML (NN F) (HYPH /) (NN F)) (NNS mice)))) (VP (VBD hybridized) (ADVP (RBR less) (RB intensely)) (PP-LOC (IN in) (NP (JJS most) (NNS mice))))) (, ,) (S (ADVP (RB however)) (NP-SBJ (NP (DT the) (NN attenuation)) (PP (IN within) (NP (DT this) (NN group)))) (VP (VBD was) (ADJP-PRD (RB highly) (JJ variable)))) (. .)) )
( (S (NP-SBJ-1 (DT A) (NN sample) (NNP northern) (NN blot)) (VP (VBZ is) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 2A))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP-MNR (RB semi-quantitatively)) (VP (VBD determined) (NP (NML (NN γ2) (NN mRNA)) (NNS amounts)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (NN γ2) (NN band) (NNS densities)) (PP (IN between) (NP (NML (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 23)))) (-RRB- -RRB-))) (CC and) (NML (NN F) (HYPH /) (NN F) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 36)))) (-RRB- -RRB-)))) (NNS mice))) (PP-TMP (VBG following) (NP (NP (NN normalization)) (PP (IN with) (NP (NN β) (HYPH -) (NN actin))))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB normalize) (NP (NNS results)) (PP (IN over) (NP (CD four) (JJ different) (NNS blots)))))) (, ,) (NP-SBJ-1 (NP (DT the) (NN ratio)) (PP (IN of) (NP (NML (JJ wild) (NN type)) (NN band) (NNS densities))) (PP-LOC (IN on) (NP (DT each) (NN blot)))) (VP (VBD was) (VP (VBN averaged) (NP-1 (-NONE- *))) (CC and) (VP (VBN normalized) (NP-1 (-NONE- *)) (PP (IN to) (NP (CD 100))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT All) (NNS samples)) (PP-LOC (IN on) (NP (DT each) (NN blot)))) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (NML (JJ wild) (NN type)) (NN band) (NNS densities))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Values)) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 2B))))) (. .)) )
( (S (NP-SBJ (NN Mean) (NML (JJ wild) (NN type)) (NN ratio)) (VP (VBD was) (NP-PRD (CD 100)) (SBAR-ADV (IN whereas) (S (NP-SBJ (NP (NN mean) (NN ratio)) (PP (IN in) (NP (NML (NN F) (HYPH /) (NN F)) (NNS samples)))) (VP (VBD was) (NP-PRD (CD 35)) (PP (IN with) (NP (NP (JJ high) (NN variability)) (PP (VBG including) (NP (NP (JJ several) (NNS mice)) (PP (IN with) (NP (NP (NNS values)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD overlapped) (PP (IN with) (NP (NML (JJ wild) (NN type)) (NNS values)))))))))))))))) (. .)) )
( (S (S (ADVP (RB Thus)) (, ,) (NP-SBJ-1 (NP (NML (NN γ2) (NN mRNA)) (NNS levels)) (PP-LOC (IN in) (NP (NN knockdown) (NNS mice)))) (VP (VBD were) (ADVP (RB dramatically)) (VP (VBN attenuated) (NP-1 (-NONE- *)) (PP (IN on) (ADJP (JJ average)))))) (, ,) (CC but) (S (NP-SBJ (DT the) (NNS levels)) (VP (VBD varied) (ADVP (RB significantly)) (PP (IN between) (NP (NNS mice))))) (. .)) )
( (HEADING (NP (NN Immunohistochemistry))) )
( (S (NP-SBJ-1 (NP (JJ Immunohistochemical) (NN staining)) (PP (IN of) (NP (NP (JJ sagittal) (NNS sections)) (VP (VBN probed) (NP (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (ADJP (NN γ2) (HYPH -) (JJ specific)) (NN antibody))))))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB assess) (NP (NP (NML (NN γ2) (NN protein)) (NN amount)) (CC and) (NP (NP (NN distribution)) (PP (IN in) (NP (DT the) (NN brain)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN sampling)) (PP (IN of) (NP (NML (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (NP (NN Fig) (NN 3A)) (-RRB- -RRB-))) (CC and) (NML (NN knockdown) (PRN (-LRB- -LRB-) (NP (NN Fig) (NN 3B)) (-RRB- -RRB-)))) (NN brain) (NNS sections)))) (VP (VBP are) (VP (VBN displayed) (NP-1 (-NONE- *)))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (CD three)) (PP (IN of) (NP (NP (DT the) (CD four) (NML (NN knockdown) (NN mouse)) (NNS sections)) (VP (VBN shown) (NP (-NONE- *))))))) (, ,) (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT a) (JJ marked) (JJ overall) (NN reduction)) (PP (IN of) (NP (NN γ2) (NN immunoreactivity)))) (PP-LOC (IN in) (NP (NP (DT all) (NNS areas)) (PP (IN of) (NP (DT the) (NN brain))) (PP (IN except) (NP (NP (DT the) (JJ outer) (NN layer)) (PP (IN of) (NP (DT the) (JJ olfactory) (NN bulb)))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NN staining) (NN intensity)) (VP (VBD was) (ADJP-PRD (JJ variable)) (PP (IN between) (NP (NN knockdown) (NNS mice))) (, ,) (PP (IN with) (S-NOM (NP-SBJ (CD one)) (VP (VBG having) (NP (ADJP (RB near) (JJ wild) (NN type)) (NN intensity))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NML (NN 3B) (, ,) (NN d))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN total)) (PP (IN of) (NP (CD 10) (NML (NN F) (HYPH /) (NN F)) (NNS mice)))) (VP (VBD were) (VP (VBN studied) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ (QP (CD Seven) (IN out) (IN of) (CD 10))) (VP (VBD had) (NP (NP (DT a) (JJ marked) (NN decrease)) (PP (IN in) (NP (NN γ2) (NN staining))) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (NN type)) (NNS controls))))))) (, ,) (CC and) (S (NP-SBJ (QP (CD three) (IN out) (IN of) (CD 10))) (VP (VBD had) (NP (NP (ADJP (ADJP (RB near) (JJ wild) (HYPH -) (NN type)) (CC or) (ADJP (JJ intermediate))) (NNS levels)) (PP (IN of) (NP (NN staining)))))) (. .)) )
( (S (NP-SBJ (NP (JJ Adjacent) (NNS sections)) (PP (IN from) (NP (DT these) (JJ same) (NNS mice)))) (VP (VBD showed) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NML (NML (NN α1)) (CC or) (NML (NN β2) (HYPH /) (CD 3))) (NN immunoreactivity)))) (CIT (-LRB- -LRB-) (NN CPM) (CC and) (NN ALD) (, ,) (JJ unpublished) (NNS observations) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (JJ Pharmacological) (NN characterization))) )
( (S (NP-SBJ (NP (NN Autoradiography)) (PP (IN on) (NP (NN brain) (NN cryostat) (NNS sections))) (PP (IN with) (S-NOM (NP-SBJ (JJ various) (NNS ligands)) (VP (VBG binding) (PP (IN to) (NP (NP (JJ selective) (NNS sites)) (PP (IN of) (NP (DT the) (NN GABAA) (HYPH -) (NN R))))))))) (VP (VBD revealed) (NP (JJ clear) (NNS differences)) (PP-LOC (IN in) (NP (DT the) (JJ homozygous) (NN γ2) (NNS knockdowns))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (UCP (ADJP (JJ heterozygous)) (CC and) (NML (JJ wild) (NN type))) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Total) (ADJP (NN flumazenil) (HYPH -) (JJ sensitive)) (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro15) (HYPH -) (CD 4513) (NN binding)) (PP (IN to) (NP (NN benzodiazepine) (NNS sites)))) (VP (VBD was) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN knockdown))) (PP-LOC (IN in) (NP (JJS most) (NN brain) (NNS regions))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (VBN reduced) (NN binding)) (PP-LOC (IN in) (NP (NP (DT the) (CD 5) (NNS mice)) (VP (VBN analyzed) (NP (-NONE- *)))))) (VP (VBD ranged) (PP (IN on) (NP (DT the) (NN average))) (PP (PP (IN from) (NP (CD 25) (NML-1 (-NONE- *RNR*)))) (PP (IN to) (NP (CD 57) (NML-1 (-NONE- *RNR*)))) (NML-1 (NN %)))) (. .)) )
( (S (PP-LOC (IN In) (NP (JJ several) (NNS regions))) (, ,) (NP-SBJ (DT the) (JJ heterozygous) (NNS mice)) (ADVP (RB also)) (VP (VBD showed) (NP (NP (NP (JJ significant) (NN reduction)) (PP (IN of) (NP (DT the) (NN binding)))) (, ,) (CC but) (NP (NP (ADJP (RB clearly) (JJR less))) (PP (IN than) (NP (DT the) (NML (JJ homozygous) (NN knockdown)) (NNS samples)))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (JJ small) (NN proportion)) (PP (IN of) (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (DT the) (JJ total) (NN binding)))))) (VP (VBD was) (ADVP (RB apparently)) (PP-PRP-PRD (IN due) (IN to) (NP (NP (NN reduction)) (PP (IN in) (NP (ADJP (NN diazepam) (HYPH -) (JJ insensitive)) (ADJP (NP (NML (NML (NN α) (CD 4)) (CC and) (NML (NN α) (CD 6))) (NN subunit)) (HYPH -) (VBG containing)) (NNS receptors))))) (, ,) (S-ADV (NP-SBJ-1 (DT this) (NN component)) (VP (VBG being) (ADVP (RB mostly)) (VP (VBN affected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (JJ cerebellar) (NN granule)) (NN cell) (NN layer))))))) (. .)) )
( (S (NP-SBJ-1 (NP (ADJP (NN GABA) (HYPH -) (JJ sensitive)) (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol) (NN binding)) (PP (IN to) (NP (NN GABA) (NN agonist) (NNS sites)))) (VP (VBD was) (RB not) (VP (VBN altered) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT any) (NN brain) (NN region))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ-2 (NP (ADJP (NN Picrotoxinin) (HYPH -) (JJ sensitive)) (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS) (NN binding)) (PP (IN to) (NP (DT the) (NML (NN GABAA) (HYPH -) (NN R)) (NNS channels)))) (VP (VBD was) (ADVP (RB little)) (VP (VBN affected) (NP-2 (-NONE- *)) (PP (IN between) (NP (DT the) (NN mouse) (NNS lines)))))) (: :) (S (NP-SBJ-1 (JJ basal) (NN binding)) (VP (VBD was) (VP (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN hippocampus)))) (CC and) (VP (VBN decreased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ cerebellar) (NN granule) (NN cell) (NN layer)) (PP (IN of) (NP (DT the) (JJ homozygous) (NN γ2) (NNS knockdowns))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))))) (. .)) )
( (S (S (NP-SBJ-1 (DT The) (ADJP (NN GABA) (HYPH -) (JJ insensitive)) (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS) (NN binding)) (VP (VBD was) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (ADVP (RB all)) (IN over) (NP (DT the) (NN brain)))))) (, ,) (CC but) (S (NP-SBJ (DT this) (NN component)) (ADVP (RB still)) (VP (VBD made) (PRT (RP up)) (NP (NP (QP (JJR less) (IN than) (CD 10)) (NN %)) (PP (IN of) (NP (DT the) (JJ basal) (NN binding))) (, ,) (PP (IN except) (PP (IN for) (NP (DT the) (JJ cerebellar) (NN granule) (NN cell) (NN layer))))))) (. .)) )
( (S (ADVP-LOC (RB There)) (, ,) (NP-SBJ (DT the) (ADJP (NN GABA) (HYPH -) (JJ insensitive)) (NN component)) (VP (VBD was) (NP-PRD (CD 20) (NN %)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (CD 10) (NN %))) (PP-LOC (IN in) (NP (DT the) (UCP (ADJP (JJ heterozygous)) (CC and) (NML (JJ wild) (NN type))) (NNS animals))))))) (. .)) )
( (HEADING (NP (JJ Behavioral) (NN characterization))) )
( (S (NP-SBJ (PRP We)) (VP (VBD examined) (NP (NP (DT the) (JJ behavioral) (NN phenotype)) (PP (IN of) (NP (DT the) (NN knockdown) (NNS mice)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (VBN elevated) (NN plus) (NN maze)) (CC and) (NP (NP (VBN forced) (NN exploration)) (PP-LOC (IN in) (NP (DT a) (JJ novel) (JJ open) (NN field)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBN elevated) (NN plus) (NN maze)) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB assess) (NP (NP (ADJP (NN anxiety) (HYPH -) (JJ like)) (NN behavior)) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NP (DT the) (JJ aversive) (NN stimulus)) (PP (IN of) (NP (DT an) (VBN elevated) (VBN exposed) (NN space))))))))))))) (. .)) )
( (S (PP (IN On) (NP (DT this) (NN test) (NN apparatus))) (, ,) (NP-SBJ (NN knockdown) (NNS mice)) (VP (VBD had) (NP (NP (NP (DT a) (NML (CD 74) (NN %)) (NN reduction)) (PP (IN in) (NP (NML (JJ open) (NN arm)) (NNS entries))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 4A)) (-RRB- -RRB-))) (CC and) (NP (NP (DT an) (NML (CD 83) (NN %)) (NN reduction)) (PP (IN in) (NP (NP (NN time)) (PP (IN on) (NP (JJ open) (NNS arms))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 4B)) (-RRB- -RRB-)))) (PP (VBN compared) (PP (IN to) (NP (NNS controls)))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (ADJP (NN anxiety) (HYPH -) (JJ like)) (NN behavior))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NN knockdown) (NNS mice)) (VP (VBD had) (NP (NP (DT the) (JJ same) (NN number)) (PP (IN of) (NP (JJ total) (NN arm) (NNS entries))) (PP (IN as) (NP (JJ wild) (NNS types) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 4C)) (-RRB- -RRB-))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (NP (DT an) (NN alteration)) (PP (IN in) (NP (NN locomotion)))) (VP (VBZ does) (RB not) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NNS differences)) (PP (IN in) (NP (ADJP (NN anxiety) (HYPH -) (JJ like)) (JJ behavioral) (NNS measures))))) (PP (IN on) (NP (DT this) (NN assay)))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Knockdown) (NNS mice)) (VP (VBD were) (ADVP (RB also)) (VP (VBN tested) (NP-1 (-NONE- *)) (PP (IN for) (NP (NP (JJ behavioral) (NN response)) (PP (IN to) (NP (DT an) (ADJP (JJ aversive)) (, ,) (ADJP (RB brightly) (VBN lit)) (NML (JJ open) (NN field)) (NN test) (NN apparatus))))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (VBN forced) (NN novelty)) (NN exploration) (NN test)))))) (. .)) )
( (S (NP-SBJ (NN Knockdown) (NNS mice)) (VP (VBD had) (NP (NP (DT a) (NML (CD 28) (NN %)) (NN reduction)) (PP (IN in) (NP (NN locomotor) (NN activity))) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (NN type)) (NNS mice))))) (SBAR-TMP (WHADVP-1 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN placed) (NP-2 (-NONE- *)) (PP-LOC (IN into) (NP (DT this) (NN test) (NN arena))) (ADVP-TMP-1 (-NONE- *T*)) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 4D)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NP (DT This) (NN reduction)) (PP (IN in) (NP (JJ exploratory) (NN behavior))) (PP-LOC (IN in) (NP (DT the) (NN knockdown) (NNS animals)))) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (ADJP (NN anxiety) (HYPH -) (JJ like)) (NN behavior))))))) (. .)) )
( (S (NP-SBJ (NP (NN Knockdown)) (PP (IN of) (NP (DT the) (NN γ2) (NN subunit)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (JJ hypnotic) (NNS responses)) (PP (IN to) (NP (NP (NML (NN benzodiazepine) (NN site)) (NNS ligands)) (CC or) (NP (NP (JJ other) (ADJP (JJ sedative) (HYPH /) (JJ hypnotic)) (NNS drugs)) (VP (VBN tested) (NP (-NONE- *))))))))) (. .)) )
( (S (S (NP-SBJ (PRP We)) (VP (VBD measured) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN righting) (NN reflex)))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB assess) (NP (NP (DT the) (JJ acute) (NN sensitivity)) (PP (IN to) (NP (ADJP (JJ sedative) (HYPH /) (JJ hypnotic)) (NNS drugs))))))))) (: ;) (S (NP-SBJ-1 (DT no) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN found) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (NP (NN injection)) (PP (IN of) (NP (NN diazepam) (, ,) (NN midazolam) (, ,) (NN zolpidem) (, ,) (NN ethanol) (, ,) (CC or) (NN pentobarbital))))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (CD 5)) (-RRB- -RRB-))))) (. .)) )
( (HEADING (NP (NP (NN Production)) (PP (IN of) (NP (NML (NN γ2) (JJ global) (NN knockout)) (NNS mice))))) )
( (S (NP-SBJ (NP (DT The) (NML (NN gene) (NN targeting)) (NN strategy)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (PRP we)) (VP (VBD used) (NP-1 (-NONE- *T*)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (DT the) (NML (NN γ2) (NN knockdown)) (NNS mice))))))))) (ADVP (RB also)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN insertion)) (PP (IN of) (NP (NP (NN loxP) (NNS sites)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP flank) (NP (NP (NN exon) (CD 8)) (PP (IN of) (NP (DT the) (NN γ2) (NN gene))))))))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Fig.) (NN 1A)))) (-RRB- -RRB-))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (IN if) (S (NP-SBJ (DT these) (NN loxP) (NNS sites)) (VP (VBD were) (ADJP-PRD (JJ functional)) (ADVP-LOC (FW in) (FW vivo)))))))) (, ,) (NP-SBJ-1 (JJ heterozygous) (VBN floxed) (NN γ2) (NNS mice)) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT a) (NML (JJ general) (NN deleter)) (ADJP (NN cre) (HYPH -) (VBG expressing)) (JJ transgenic) (NN mouse) (NN line) (PRN (-LRB- -LRB-) (NP (NNP JAX) (NNP Laboratory)) (, ,) (NP (NN stock) (SYM #) (CD 003376)) (-RRB- -RRB-))) (SBAR (WHADVP-3 (WRB where)) (S (NP-SBJ-2 (DT the) (NN cre) (NN transgene)) (VP (VBD was) (VP (VBN driven) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (ADJP (RB ubiquitously) (VBN expressed)) (JJ human) (NML (NN beta) (NN actin)) (NN promoter))) (ADVP-LOC-3 (-NONE- *T*)) (PRN (-LRB- [) (NP (CD 24)) (-RRB- ])))))))))) (. .)) )
( (S (NP-SBJ (NP (NML (NN Restriction) (NN fragment) (NN polymorphism)) (NN analysis)) (PP (IN by) (NP (NNP Southern) (NN blotting)))) (VP (VBD confirmed) (NP (NP (DT the) (NN deletion)) (PP (IN of) (NP (JJ genomic) (NN DNA))) (PP (IN between) (NP (NN loxP) (NNS sites))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN predicted) (NP-1 (-NONE- *)) (PP (IN from) (NP (NN Fig.) (NN 1A)))))) (, ,) (NP-SBJ (NN Probe) (NN A)) (VP (VBD hybridized) (PP (IN to) (NP (DT a) (NML (CD 6.6) (NN kb)) (NN BglII) (NN fragment))) (PP (IN from) (NP (DT the) (VBN recombined) (NN knockout) (NN allele))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (IN if) (S (NP-SBJ (NP (ADJP (NN cre) (HYPH -) (VBN mediated)) (NN recombination)) (CC and) (NP (NP (NN deletion)) (PP (IN of) (NP (NN exon) (CD 8))))) (VP (VBD resulted) (PP (IN in) (NP (DT a) (JJ null) (NN allele))))))))) (, ,) (NP-SBJ-1 (NP (NNS mice)) (ADJP (ADJP (JJ hemizygous) (PP (IN for) (NP (DT the) (NN cre) (NN transgene)))) (CC and) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (VBN recombined) (NN γ2) (NN allele) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (NN f)) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NNS mice)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (VBN floxed) (, ,) (JJ non-recombined) (NN γ2) (NN allele) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (NN F)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (NP (NP (CD 10.2) (NN %)) (-LRB- -LRB-) (NP (QP (CD 14) (IN of) (CD 137))) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NN offspring)) (PP (IN from) (NP (DT this) (NN mating) (NN strategy)))))) (VP (VBD were) (ADJP-PRD (JJ homozygous) (PP (IN for) (NP (DT the) (JJ recombined) (NN locus))) (PRN (-LRB- -LRB-) (NP (NN f) (HYPH /) (NN f)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This) (NN ratio)) (VP (VBZ is) (PP-PRD (IN in) (NP (NP (NN agreement)) (PP (IN with) (NP (NP (DT the) (CD 12.5) (NN %)) (VP (VBN predicted) (NP (-NONE- *)) (PP (IN from) (NP (JJ Mendalian) (NN genetics))))))))) (. .)) )
( (S (NP-SBJ (QP (CD 13) (IN of) (DT the) (CD 14)) (NML (NN f) (HYPH /) (NN f)) (NNS mice)) (VP (VBD died) (PP-TMP (IN within) (NP (NP (CD three) (NNS days)) (PP (IN of) (NP (NN birth)))))) (. .)) )
( (S (NP-SBJ (CD One) (NML (NN f) (HYPH /) (NN f)) (NN mouse)) (VP (VBD survived) (PP-TMP (IN until) (NP (JJ postnatal) (NN day) (CD 21)))) (. .)) )
( (S (NP-SBJ (NP (DT This) (JJ neonatal) (NN lethality)) (PP (IN of) (NP (NML (NN γ2) (NN f) (HYPH /) (NN f)) (NNS mice)))) (VP (VBZ is) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (DT those)) (VP (VBN found) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NP (DT the) (JJ global) (NN γ2) (NNS knockouts)) (PP (IN of) (NP (NP (NNP Günther)) (ADVP-ETC (FW et) (FW al.)) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))))) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB also)) (VP (VBD had) (NP (NP (DT a) (NN deletion)) (PP (IN of) (NP (NN exon) (CD 8)))))))))))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP-SBJ (NP (NP (ADJP (NN cre) (HYPH -) (VBN mediated)) (NN recombination)) (PP (IN of) (NP (DT the) (NN loxP) (NNS sites)))) (CC and) (NP (NP (NN deletion)) (PP (IN of) (NP (NN exon) (CD 8))))) (VP (VBZ inactivates) (NP (DT the) (NN γ2) (NN gene)))))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ (NP (JJ Genetic) (NN dissection)) (PP (IN of) (NP (DT the) (NML (NN GABAA) (HYPH -) (NN R)) (NN system)))) (VP (VBZ is) (VP (VBG yielding) (NP (NP (JJ remarkable) (NNS insights)) (PP (IN into) (NP (NP (NML (NN GABAA) (HYPH -) (NN R)) (NN biology)) (CC and) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NN action))) (PP (IN of) (NP (JJ various) (NNS drugs))))))))) (. .)) )
( (S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP report) (NP (NP (DT the) (NN establishment)) (PP (IN of) (NP (NP (NP (DT a) (JJ new) (NML (NN GABAA) (HYPH -) (NN R)) (NN mutant) (NN mouse) (NN model)) (, ,) (NP (NP (CD one)) (PP (IN with) (NP (NP (VBN attenuated) (NN expression)) (PP (IN of) (NP (DT the) (NN γ2) (NN subunit))))))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ averages) (NP (NP (QP (SYM ~) (CD 35)) (NN %)) (PP (IN of) (NP (JJ normal) (NNS levels))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (JJ novel) (NML (NN γ2) (NN knockdown)) (NN model)) (VP (VBZ has) (NP (NP (JJ several) (JJ unique) (NNS features)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP make) (S (NP-SBJ-1 (PRP it)) (ADJP-PRD (JJ useful)))))))) (. .)) )
( (S (ADVP (RB First)) (, ,) (PP (VBN compared) (PP (IN to) (NP (NP (JJ global) (NNS knockouts)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP die) (PP (IN as) (NP (NNS neonates))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ])))))))) (, ,) (NP-SBJ (NN knockdown) (NNS mice)) (VP (VBP have) (NP (JJ normal) (NN viability))) (. .)) )
( (S (ADVP (RB Secondly)) (, ,) (NP-SBJ (NP (DT the) (VBN graded) (NNS levels)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (NN γ2)) (PRN (-LRB- -LRB-) (NP (NN range)) (NP (NP (QP (CD 10) (SYM –) (CD 95)) (NN %)) (PP (IN of) (NP (JJ normal)))) (-RRB- -RRB-))))) (PP-LOC (IN in) (NP (DT the) (NN mutant) (NNS mice)))) (VP (MD could) (VP (VB be) (ADJP-PRD (JJ useful)) (PP (IN in) (NP (NP (NNS studies)) (VP (VBG correlating) (NP (NN phenotype)) (PP (IN with) (NP (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN γ2) (NN protein)))) (ADJP (JJ present))))))))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ-1 (NML (JJ global) (NN knockout)) (NNS mice)) (VP (MD can) (VP (VB be) (VP (VBN created) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT these) (NNS mice))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG crossing) (PP (IN to) (NP (NP (DT a) (NN Cre) (NN recombinase)) (VP (VBG expressing) (NP (NML (JJ global) (NN deleter)) (NN mouse) (NN line))))))))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (NP (DT the) (NNS mice)) (VP (VBN reported) (NP (-NONE- *)) (ADVP (RB here)))) (VP (VBP represent) (NP (NP (DT a) (JJ useful) (NN addition)) (PP (IN to) (NP (NP (DT the) (ADJP (RB rapidly) (VBG expanding)) (NN arsenal)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (JJ genetic) (NNS alterations)) (PP-LOC (IN in) (NP (NP (DT the) (NN γ2) (NN subunit)) (PP (IN of) (NP (DT the) (NN GABAA) (HYPH -) (NN R))))))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (ADJP (JJ homozygous) (CC and) (JJ heterozygous)) (JJ global) (NN γ2) (NNS knockouts) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ])))))) (, ,) (NP-SBJ-1 (NP (JJ conditional) (NML (NN γ2) (NN knockout)) (NNS mice) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ]))) (, ,) (NP (NP (NN knockin) (NNS mice)) (PP (IN with) (NP (NP (NP (DT a) (NN point) (NN mutation)) (PP (IN in) (NP (NN γ2)))) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ eliminates) (NP (NML (NML (NN zolpidem)) (CC and) (NML (JJ inverse) (NN agonist) (NN β) (HYPH -) (NN carboline))) (NN sensitivity)) (PRN (-LRB- [) (NP (CD 26) (, ,) (CD 27)) (-RRB- ])))))))) (, ,) (NP (NP (JJ global) (NN knockout)) (PP (IN of) (NP (NP (DT the) (NML (JJ long) (NN splice)) (NN variant)) (PP (IN of) (NP (NN γ2))))) (PRN (-LRB- [) (NP (CD 28)) (-RRB- ]))) (, ,) (CC and) (NP (NP (JJ transgenic) (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP express) (NP (NP (CC either) (DT the) (ADJP (JJ long) (CC or) (JJ short)) (NN splice) (NNS variants)) (PP (IN of) (NP (DT the) (NN γ2) (NN subunit)))) (PRN (-LRB- [) (NP (CD 29)) (-RRB- ]))))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ (NP (DT An) (JJ important) (JJ unexpected) (NN finding)) (PP (IN from) (NP (DT this) (NN study)))) (VP (VBD was) (NP-PRD (NP (DT the) (ADJP (RB extremely) (JJ variable)) (NN degree)) (SBAR (WHPP-1 (IN to) (WHNP (WDT which))) (S (NP-SBJ (NP (DT the) (JJ genetic) (NN alteration)) (PP (IN of) (NP (DT the) (NN γ2) (NN locus)))) (VP (VBD changed) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN γ2) (NN product)) (VP (VBN produced) (NP (-NONE- *)))))) (PP-1 (-NONE- *T*))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NML (NN γ2) (NN knockdown)) (NN model)) (VP (VBD was) (VP (VBN produced) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN insertion)) (PP (IN of) (NP (NN NEO))) (PP (IN into) (NP (JJ intronic) (NN DNA))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN strategy)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (NP-1 (-NONE- *)) (ADVP-TMP (RB previously)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (JJ hypomorphic) (NNS alleles))))) (PRN (-LRB- [) (NP (NP (CD 11)) (PP (SYM -) (NP (CD 23)))) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NP (NN Creation)) (PP (IN of) (NP (JJ hypomorphic) (NNS alleles)))) (VP (VBZ has) (VP (VBN been) (ADJP-PRD (JJ useful)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG determining) (NP (NP (NN function)) (PP (IN of) (NP (NP (DT the) (NN gene)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ has) (VP (VBN been) (VP (VBN targeted) (NP-1 (-NONE- *))))))))))))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (NNS cases)) (SBAR (WHADVP-2 (WRB where)) (S (NP-SBJ (NP (JJ complete) (NN disruption)) (PP (IN of) (NP (DT the) (NN gene)))) (VP (VBZ is) (ADJP-PRD (JJ lethal)) (ADVP-2 (-NONE- *T*)) (PRN (-LRB- [) (NP (CD 12)) (, ,) (NP (NP (CD 14)) (PP (SYM -) (NP (CD 16)))) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Intronic) (NN insertion)) (PP (IN of) (NP (NN NEO)))) (VP (VBZ creates) (NP (JJ hypomorphic) (NNS alleles)) (PP-MNR (CC either) (PP (IN through) (NP (NP (NP (JJ cryptic) (NN splicing) (NNS signals)) (PP-LOC (IN in) (NP (DT the) (NN NEO) (NN gene)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP lead) (PP (IN to) (NP (NP (DT a) (NN frameshift)) (CC or) (NP (NP (NNS alterations)) (PP (IN in) (NP (NN splicing))))))))))) (, ,) (CC or) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (RB down) (VBG regulating) (NP (NN gene) (NN expression)) (PP-MNR (IN through) (NP (DT an) (JJ unknown) (NN mechanism)))))) (PRN (-LRB- [) (NP (NP (CD 14)) (PP (SYM -) (NP (CD 16)))) (-RRB- ])))) (. .)) )
( (S (PP (IN In) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (DT these) (NNS studies))))) (, ,) (NP-SBJ (DT the) (NNS authors)) (POS ') (VP (VBD reported) (NP (NP (DT a) (NML (QP (CD 5) (SYM –) (CD 25)) (NN %)) (NN level)) (PP (IN of) (NP (NN expression))) (PP (IN from) (NP (DT the) (VBN targeted) (NN gene))))) (. .)) )
( (SINV (ADVP (RB However)) (, ,) (PP-LOC (IN in) (NP (NP (NN none)) (PP (IN of) (NP (DT these) (ADJP (RB previously) (VBN described)) (JJ hypomorphic) (NNS alleles))))) (VBD was) (NP-SBJ-1 (JJ extensive) (NN variability)) (VP (VBN reported) (NP-1 (-NONE- *))) (. .)) )
( (S (NP-SBJ (NP (DT The) (ADJP (NN γ2) (VBN targeted)) (JJ homozygous) (NNS mice)) (PP (IN in) (NP (DT this) (NN study)))) (ADVP (RB clearly)) (VP (VBP display) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NN γ2) (NML (NML (NN mRNA)) (CC and) (NML (NN protein) (NNS levels))))))) (. .)) )
( (S (NP-SBJ (JJ Semi-quantitative) (NML (NNP northern) (NN blot)) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (QP (CD 4) (IN out) (IN of) (CD 5)) (JJ homozygous) (NN knockdown) (NNS mice)) (VP (VBD showed) (, ,) (PP (IN on) (ADJP (JJ average))) (, ,) (NP (NP (DT a) (NML (CD 70) (NN %)) (NN reduction)) (PP (IN of) (NP (NN γ2) (NN mRNA) (NNS levels)))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ (QP (CD 1) (IN out) (IN of) (CD 5)) (NNS mice)) (VP (VBD had) (NP (NN γ2) (NN mRNA)) (PP (IN at) (NP (NP (DT a) (NN level)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (ADJP-PRD (JJ similar) (PP (IN to) (NP (JJ wild) (NN type)))))))))))))))) (. .)) )
( (S (NP-SBJ (JJ Immunohistochemical) (NNS data)) (VP (VBD were) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NML (NNP northern) (NN blot)) (NNS data))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN reason)) (PP (IN for) (NP (DT this) (ADJP (RB highly) (JJ variable)) (NN expression))) (PP (IN within) (NP (JJ homozygous) (NN knockdown) (NNS mice)))) (VP (VBZ has) (S (NP-SBJ-1 (-NONE- *)) (ADVP-TMP (RB yet)) (VP (TO to) (VP (VB be) (VP (VBN determined) (NP-1 (-NONE- *))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ mixed) (NN background)) (PP (IN of) (NP (NN Strain) (NML (NML (NN 129S1) (HYPH /) (NN X1)) (CC and) (NML (NN C57BL6) (HYPH /) (NN J)))))) (VP (MD may) (RB not) (VP (VB be) (NP-PRD (DT the) (NN cause)) (PP (VBN given) (SBAR (IN that) (S (NP-SBJ (JJ other) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN observed) (NP (NP (JJ substantial) (NN variability)) (PP (IN in) (NP (NN expression)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ similar) (NN background) (NNS strains)) (PRN (-LRB- [) (NP (CD 11) (, ,) (CD 18) (, ,) (CD 20)) (-RRB- ]))))))))))) (. .)) )
( (S (NP-SBJ (NP (NN Gender)) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (NN variability)))))) (ADVP (RB also)) (VP (VBZ is) (RB not) (ADJP-PRD (JJ likely)) (PP (VBN given) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (NN set)) (PP (IN of) (NP (NP (CD three) (JJ male) (NN knockdown) (NNS siblings)) (NP-1 (-NONE- *ICH*))))) (VP (VBD exhibited) (NP (NP (DT the) (JJ full) (NN range)) (PP (IN of) (NP (NN γ2) (NNS levels)))) (: ;) (NP-1 (S-NOM (NP-SBJ (CD one)) (VP (VBG being) (PP-PRD (IN near) (NP (NML (JJ wild) (NN type)) (NNS levels))))) (, ,) (S-NOM (NP-SBJ (DT another)) (VP (VBG being) (PP-PRD (IN at) (NP (DT an) (JJ intermediate) (NN level))))) (, ,) (CC and) (S-NOM (NP-SBJ (DT the) (JJ third)) (VP (VBG exhibiting) (NP (ADJP (RB severely) (VBN attenuated)) (NN expression)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Further) (NN study)) (SBAR (WHADVP-2 (-NONE- *0*)) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (DT this) (NN variability)))) (ADVP-MNR-2 (-NONE- *T*))))))) (VP (VBZ needs) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN undertaken) (NP-1 (-NONE- *))))))) (. .)) )
( (S (ADVP (RB Nevertheless)) (, ,) (NP-SBJ (NP (NNS investigators)) (SBAR (WHNP-1 (WP who)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP desire) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (DT a) (JJ hypomorphic) (NN allele)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG inserting) (NP (NN NEO)) (PP (IN into) (NP (JJ intronic) (NN DNA))))))))))))) (VP (MD should) (VP (VB take) (PP (IN into) (NP (NN consideration))) (NP (NP (NP (DT the) (NN variability)) (PP (IN of) (NP (NN gene) (NN expression)))) (VP (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (DT this) (NN study))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN extent)) (PP (IN of) (NP (NN variability)))) (VP (MD may) (VP (VB be) (ADJP-PRD (NN locus) (JJ dependent)))) (. .)) )
( (S (NP-SBJ (NP (NN Knockdown)) (PP (IN of) (NP (ADJP (NP (NN γ2) (NN subunit)) (VBG containing)) (NN GABAA) (HYPH -) (NNS Rs)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ behavioral) (NNS changes)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (VBN increased) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NN behavior)))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NN mutant) (NN knockdown) (NNS mice)) (VP (VBD showed) (NP (NP (VBN reduced) (JJ exploratory) (NN behavior)) (PP (IN for) (NP (NP (DT a) (JJ novel) (NML (JJ open) (NN field)) (NN apparatus)) (CC and) (NP (NP (DT the) (JJ open) (NNS arms)) (PP (IN of) (NP (DT the) (VBN elevated) (NN plus) (NN maze)))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Similar) (NNS changes)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN γ2) (JJ global) (JJ heterozygous) (NN knockout)) (NNS mice))) (PRN (-LRB- [) (NP (CD 10)) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB Together)) (, ,) (NP-SBJ (DT these) (NNS results)) (VP (VBP strengthen) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP-SBJ (NML (NN GABAA) (HYPH -) (NN R)) (NN dysfunction)) (VP (MD may) (VP (VB be) (NP-PRD (NP (DT an) (JJ underlying) (NN cause)) (PP (IN of) (NP (NN anxiety) (NNS disorders)))) (PP-LOC (IN in) (NP (NNS humans))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NN mutant) (NN mouse) (NNS models)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ useful)) (PP (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG dissecting) (NP (NP (DT the) (NN etiology)) (PP (IN of) (NP (DT this) (JJ pervasive) (NN condition))))))) (CC and) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG developing) (NP (JJ effective) (JJ therapeutic) (NNS interventions)))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ (NP (NNS brains)) (PP (IN from) (NP (NN γ2) (NN knockdown) (NNS mice)))) (VP (VBD demonstrated) (NP (NP (ADJP (RB significantly) (VBN decreased)) (NN binding)) (PP (IN of) (NP (NP (DT the) (NN benzodiazepine) (NN site) (NN ligand)) (, ,) (NP (NN Ro15) (HYPH -) (CD 4513)))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBD was) (VP (VBN expected) (NP-1 (-NONE- *)) (SBAR-PRP (IN since) (S (NP-SBJ-2 (NN benzodiazepine) (NN binding) (NNS sites)) (VP (VBP are) (VP (VBN located) (NP-2 (-NONE- *)) (PP-LOC (IN at) (NP (NP (DT the) (NN interface)) (PP (IN of) (NP (NP (JJ select) (NML (NN alpha) (CC and) (NN γ2)) (NNS subunits)) (PP (IN of) (NP (DT the) (NN GABAA) (HYPH -) (NN R))))))) (PRN (-LRB- [) (NP (CD 30)) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN reduction)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Ro15) (HYPH -) (CD 4513)) (NN binding))))) (VP (VBP agree) (PP (IN with) (NP (NP (DT those)) (PP (IN from) (NP (NML (JJ global) (NN γ2) (NN knockout)) (NNS mice) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ])))))) (SBAR-ADV (IN in) (DT that) (S (NP-SBJ (NP (NN deficiency)) (PP (IN of) (NP (DT the) (NN γ2) (NN subunit)))) (VP (VBZ abolishes) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (DT the) (NML (NN benzodiazepine) (HYPH -) (NN site)) (NNS ligands)))))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NML (JJ global) (JJ heterozygous) (NN γ2) (NN knockout)) (NNS mice)) (VP (VBP have) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN total) (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro15) (HYPH -) (CD 4513)) (NN binding)))) (PP-LOC (IN in) (NP (JJS most) (NN brain) (NNS regions))) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))) (, ,) (CC and) (S (NP-SBJ (NP (DT the) (JJ present) (NNS data)) (PP (IN on) (NP (DT the) (NN γ2) (NN knockdown)))) (VP (VBP show) (NP (NP (DT a) (ADJP (RB very) (JJ similar)) (NN pattern)) (PP (IN of) (NP (VBN reduced) (NN binding)))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (CD 5) (NN knockdown) (NNS brains)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (PRP we)) (VP (VBD examined) (NP-1 (-NONE- *T*)))))) (VP (VBD had) (ADVP (RB actually)) (NP (NP (DT a) (JJR greater) (NN reduction)) (PP (IN in) (NP (NN benzodiazepine) (NN binding))) (PP (IN than) (NP (NP (DT the) (NN γ2) (JJ heterozygous) (JJ global) (NNS knockouts)) (VP (VBN published) (NP (-NONE- *)) (ADVP-TMP (RB earlier)))))) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ]))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Similar) (PP (IN to) (NP (DT the) (NN γ2) (JJ heterozygous) (NNS knockouts))))) (, ,) (NP-SBJ-1 (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol)) (NN binding)) (VP (VBD was) (RB not) (VP (VBN affected) (NP-1 (-NONE- *)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ-2 (NP (DT the) (NN reduction)) (PP (IN of) (NP (DT the) (NN γ2) (NN subunit) (NNS levels)))) (VP (VBZ is) (RB not) (VP (VBN compensated) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ increased) (NN δ) (NN subunit)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (RB largely) (JJ responsible) (PP (IN for) (NP (NP (DT the) (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol)) (NN binding) (NN signal)) (PP-LOC (IN in) (NP (NN brain) (NNS sections))))))))))) (PRN (-LRB- [) (NP (CD 32)) (-RRB- ])))))))))) (. .)) )
( (S (S (NP-SBJ-1=2 (NP (DT The) (JJ basal) (NN binding)) (PP (IN of) (NP (NP (DT the) (NML (NN ion) (NN channel)) (NN ligand)) (NP (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS))))) (VP (VBZ is) (ADVP (RB usually)) (VP=3 (VBN reduced) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-4=2 (NP (PRP$ its) (NN sensitivity)) (PP (IN to) (NP (NN GABA)))) (VP=3 (VBD increased) (NP-4 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NN addition)) (PP (IN of) (NP (NN γ2) (NNS subunits))))) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))) (. .)) )
( (S (S (PP-LOC (DT Both) (PP (IN in) (NP (DT the) (ADJP (NN γ2) (JJ heterozygous)) (JJ global) (NN knockout))) (CC and) (PP (IN in) (NP (PRP$ our) (JJ homozygous) (NN knockdown)))) (, ,) (NP-SBJ-1 (NN TBPS) (NN binding)) (VP (VBD was) (VP (VBN increased) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT some) (NN brain) (NNS regions)))))) (, ,) (CC and) (, ,) (S (ADVP (RBR more) (RB consistently)) (, ,) (NP-SBJ (EX there)) (VP (VBD emerged) (NP-TPC (NP (DT a) (`` ``) (ADJP (NN GABA) (HYPH -) (JJ insensitive)) ('' '') (NN receptor) (NN population)) (PP (IN with) (NP (NP (JJ widespread) (NN distribution)) (PP-LOC (IN in) (NP (DT the) (NN brain)))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ indicates) (NP (NP (NN production)) (PP (IN of) (NP (NN GABAA) (HYPH -) (NNS Rs))) (PP (IN with) (NP (DT an) (NN αβ) (NN configuration))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS receptors)) (VP (VP (VP (VBP bind) (ADVP (RB strongly)) (NP (DT the) (NN agonist))) (CC and) (VP (VBP have) (NP (VBN reduced) (NN channel) (NN conductance) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ]))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADVP (RB perhaps)) (VP (VBG reflecting) (NP (NP (ADJP (RB only) (JJ partial)) (NN agonist) (NN efficacy)) (PP (IN of) (NP (NN GABA))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (MD would) (VP (VB explain) (NP (NP (DT the) (VBN reduced) (JJ allosteric) (NN efficacy)) (PP (IN of) (NP (NN GABA))) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG abolishing) (NP (NN TBPS) (NN binding)))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (DT these) (NNS receptors)) (VP (VBP have) (ADVP (RBS most) (RB likely)) (NP (JJ non-synaptic) (, ,) (JJ non-clustered) (NN localization)) (SBAR-PRP (IN as) (S (NP-SBJ (PRP they)) (VP (VBP lack) (NP (DT the) (NN γ2) (NN subunit))))) (PRN (-LRB- [) (NP (CD 10) (, ,) (CD 33)) (-RRB- ]))) (. .)) )
( (S (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (DT the) (ADJP (RB partially) (NN γ2) (VBN depleted)) (NNS mice)) (VP (MD may) (VP (VB have) (NP (NP (ADJP (NP (NN brain) (NN region)) (HYPH -) (JJ selective)) (NNS alterations)) (PP-LOC (IN in) (NP (ADJP (JJ synaptic) (CC and) (JJ extrasynaptic)) (NNS receptors))))))) (, ,) (CC and) (S (NP-SBJ (DT the) (VBN reduced) (JJ synaptic) (NML (NN GABAA) (HYPH -) (NN R)) (NN function)) (VP (MD might) (VP (VB correlate) (PP (IN with) (NP (DT the) (JJ anxious) (NN phenotype)))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (ADVP (RB surprisingly)) (, ,) (NP-SBJ (NP (DT the) (NML (JJ high) (HYPH -) (NN dose)) (JJ hypnotic) (NNS effects)) (PP (IN of) (NP (NP (DT the) (NN benzodiazepine) (NN site) (NNS ligands)) (NP (NN diazepam) (, ,) (NN zolpidem) (CC and) (NN midazolam))))) (VP (VBD were) (ADJP-PRD (JJ unchanged)) (PP-LOC (IN in) (NP (DT the) (NN knockdown) (NNS mice)))) (. .)) )
( (S (NP-SBJ-1 (JJ Several) (NNS hypotheses)) (VP (MD can) (VP (VB be) (VP (VBN generated) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB explain) (NP (NP (DT the) (NN discrepancy)) (PP (IN between) (NP (NP (VBN decreased) (NN benzodiazepine) (NN ligand) (NN binding)) (CC and) (NP (JJ unchanged) (JJ hypnotic) (NNS effects))))))))))) (. .)) )
( (S (NP-SBJ (CD One) (NN possibility)) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ-1 (NP (RB only) (DT a) (NN threshold) (NN level)) (PP (IN of) (NP (ADJP (NN γ2) (VBG containing)) (NN GABAA) (HYPH -) (NNS Rs)))) (VP (VBP are) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (JJ hypnotic) (NNS responses)) (PP (IN to) (NP (NNS benzodiazepines)))))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB completely)) (VP (VBP lack) (NP (NN γ2)))))) (VP (VP (VBD had) (NP (NP (QP (RB only) (CD 6)) (NN %)) (PP (IN of) (NP (NN benzodiazepine) (NN binding)))) (PP (VBN compared) (PP (IN to) (NP (NML (JJ wild) (NN type)) (NNS mice))))) (CC and) (VP (VBD were) (ADJP-PRD (JJ insensitive) (PP (IN to) (NP (NP (DT the) (JJ hypnotic) (NNS effects)) (PP (IN of) (NP (NN diazepam)))))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Likewise)) (, ,) (NP-SBJ (NP (NNS mice)) (PP (IN with) (NP (NP (NP (DT a) (NN point) (NN mutation)) (PP-LOC (IN in) (NP (NN γ2)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD eliminated) (NP (NP (NN response)) (PP (IN to) (NP (NN zolpidem)))))))))) (VP (VBD eliminated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT this) (NN benzodiazepine) (NN site) (NN ligand)))) (PRN (-LRB- [) (NP (CD 26)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-3 (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ seems) (S (NP-SBJ-3 (-NONE- *)) (ADJP-PRD (JJ likely))) (SBAR-1 (IN that) (S (NP-SBJ-4 (NP (NP (DT the) (QP (CD 20) (SYM –) (CD 40)) (NN %)) (PP (IN of) (NP (ADJP (NN benzodiazepine) (JJ sensitive)) (NNS receptors)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP remain) (PP-LOC-PRD (IN in) (NP (DT the) (NN knockdown) (NNS mice))))))) (VP (VBP are) (ADJP-PRD (JJ enough) (S (NP-SBJ-4 (-NONE- *PRO*)) (VP (TO to) (VP (VB mediate) (NP (NP (DT the) (JJ hypnotic) (NN effect)) (PP (IN of) (NP (NN benzodiazepine) (NN site) (NNS ligands)))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBZ is) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (NML (NN positron) (NN emission) (NN tomography)) (NNS studies)) (PP-LOC (IN in) (NP (NNS humans)))) (, ,) (SBAR (WHPP-3 (IN in) (WHNP (WDT which))) (S (NP-SBJ-2 (NP (RB only) (DT a) (JJ small) (NN proportion)) (PP (IN of) (NP (DT the) (NN benzodiazepine) (NNS sites)))) (VP (VBP need) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN occupied) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NN lorazepam) (CC and) (NN zolpidem))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB induce) (NP (NP (JJ clinical) (NNS effects)) (PP (JJ such) (IN as) (NP (NN sedation))))))) (PP-3 (-NONE- *T*)))))) (PRN (-LRB- [) (NP (CD 34) (, ,) (CD 35)) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (MD may) (ADVP (RB thus)) (VP (VB be) (NP-PRD (NP (JJ spare) (NNS receptors)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VP (MD can) (VP (VB be) (VP (VBN measured) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ biochemical) (NNS techniques)))))) (CC but) (VP (VBP are) (RB not) (VP (VBN needed) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NML (JJ whole) (NN animal)) (JJ pharmacological) (NNS effects))))))))))) (. .)) )
( (S (NP-SBJ (DT Another) (NN hypothesis)) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ (NP (NN knockdown)) (PP (IN of) (NP (NN γ2)))) (VP (VBZ does) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ proportional) (NN reduction)) (PP (IN in) (NP (DT all) (ADJP (NN γ2) (VBG containing)) (NN GABAA) (HYPH -) (NNS Rs)))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Recent) (NNS studies)) (VP (VBN conducted) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN knockin) (NNS mice)) (PP (IN with) (NP (NP (DT a) (NN point) (NN mutation)) (PP-LOC (IN at) (NP (DT the) (NML (NN benzodiazepine) (NN binding)) (NN site))))))))) (VP (VBP have) (VP (VBN attributed) (NP (ADJP (NP (NN α1) (CC and) (NN α2)) (VBG containing)) (NML (NN GABAA) (HYPH -) (NNS Rs))) (PP (IN to) (NP (NP (DT the) (NN mediation)) (PP (IN of) (NP (ADJP (NN benzodiazepine) (HYPH -) (VBN induced)) (NML (NN sedation) (CC and) (NN anxiolysis)))))) (, ,) (ADVP (RB respectively)) (PRN (-LRB- [) (NP (CD 4)) (, ,) (NP (NP (CD 36)) (PP (SYM -) (NP (CD 38)))) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Perhaps)) (NP-SBJ (NML (NN γ2) (NN knockdown)) (NNS mice)) (VP (VBP have) (NP (NP (JJ disproportionate) (NNS decreases)) (PP (IN in) (NP (NP (ADJP (JJ non-α1) (VBG containing)) (NNS receptors)) (, ,) (NP (ADVP (FW e.g.)) (, ,) (ADJP (NP (NN α2) (CC or) (NN α3)) (VBG containing)) (NN receptor) (NNS isoforms)))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ possible)) (SBAR-1 (IN that) (S (PP-LOC (IN in) (NP (PRP$ our) (NML (NN γ2) (NN knockdown)) (NNS mice))) (, ,) (NP-SBJ-3 (NP (DT the) (NN number)) (PP (IN of) (NP (NML (NN α) (NN 2βxγ2)) (NN GABAA) (HYPH -) (NNS Rs)))) (VP (VBZ is) (ADVP (RB greatly)) (VP (VBN reduced) (NP-3 (-NONE- *)) (SBAR-ADV (IN while) (S (NP-SBJ (NP (DT the) (NN number)) (PP (IN of) (NP (NML (NN α) (NN 1βxγ2)) (NNS receptors)))) (VP (VBZ is) (RB not) (ADJP-PRD (-NONE- *?*))))) (, ,) (SBAR-ADV (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ remains) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN studied) (NP-2 (-NONE- *))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (MD could) (VP (VB be) (VP (VBN tested) (NP-1 (-NONE- *)) (PP-MNR (PP (IN by) (NP (NP (JJ immunohistochemical) (NNS methods)) (VP (VBG using) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NN α2) (CC and) (NN α3))))))) (CC or) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG testing) (PP (IN for) (NP (NP (NNS changes)) (PP (IN in) (NP (ADJP (NN zolpidem) (JJ insensitive)) (NN binding)))))))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Changes)) (PP (IN in) (NP (NN subunit) (NN trafficking)))) (VP (MD may) (ADVP (RB also)) (VP (VB play) (NP (DT a) (NN role)))) (. .)) )
( (S (NP-SBJ (NP (NNP Essrich)) (ADVP-ETC (FW et) (FW al.)) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))) (VP (VBD established) (NP (JJ strong) (NN evidence) (SBAR (IN that) (S (NP-SBJ-1 (NN GABAA) (HYPH -) (NNS Rs)) (VP (VBP are) (VP (VBN clustered) (NP-1 (-NONE- *)) (PP-LOC (IN at) (NP (DT the) (NN synapse))) (PP-MNR (IN through) (NP (NP (JJ indirect) (NNS interactions)) (PP (IN between) (NP (NN γ2) (CC and) (NN gephyrin))))))))))) (. .)) )
( (S (NP-SBJ (JJ Enough) (NN clustering)) (VP (MD may) (VP (VB remain) (PP-LOC (IN in) (NP (DT the) (NN knockdown) (NNS mice))) (SBAR-MNR (JJ such) (IN that) (S (NP-SBJ (NN drug) (NN response)) (VP (VBZ does) (RB not) (VP (VB change))))))) (. .)) )
( (S (S (ADVP (RB Alternatively)) (, ,) (NP-SBJ (NP (JJ synaptic) (NN clustering)) (PP (IN of) (NP (NN GABAA) (HYPH -) (NNS Rs)))) (VP (MD may) (RB not) (VP (VB be) (ADJP-PRD (JJ important) (PP (IN for) (NP (NP (JJ behavioral) (NNS responses)) (PP (IN to) (NP (NNS benzodiazepines))))))))) (, ,) (CC and) (S (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ possible) (SBAR-1 (IN that) (S (NP-SBJ (NNS benzodiazepines)) (VP (VBP potentiate) (NP (NP (DT the) (JJ extrasynaptic) (NML (NN GABAA) (HYPH -) (NN R)) (NNS responses)) (VP (VBN determined) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN electrophysiology))) (PP-LOC (IN in) (NP (NN brain) (NNS slices))))))))) (PRN (-LRB- [) (NP (CD 39)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ possible)) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT the) (JJ high) (NN variability)) (PP (IN in) (NP (NN γ2) (NNS levels))) (PP-LOC (IN in) (NP (NP (DT the) (NN brain)) (PP (IN of) (NP (NN knockdown) (NNS mice)))))) (VP (VBD masked) (NP (NP (DT any) (NN change)) (PP (IN in) (NP (NP (JJ behavioral) (NN response)) (PP (IN to) (NP (DT these) (NNS drugs)))))))))) (. .)) )
( (S (PP (IN In) (NP (NN hindsight))) (, ,) (NP-SBJ (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (MD would) (VP (VB have) (VP (VBN been) (ADJP-PRD (JJ useful)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB quantify) (NP (NN γ2) (NNS levels)) (PP-LOC (IN in) (NP (NP (DT the) (JJ same) (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (VP (VBN used) (NP-2 (-NONE- *)) (PP (IN for) (NP (DT the) (NML (JJ behavioral) (NN sensitivity)) (NNS studies))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (S-1 (-NONE- *EXP*))) (VP (MD would) (VP (VB be) (ADJP-PRD (JJ interesting)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB see) (SBAR (IN if) (S (NP-SBJ (NN sensitivity)) (VP (VBD correlated) (PP (IN with) (NP (NN γ2) (NNS levels))) (PP-LOC (IN on) (NP (DT an) (NML (JJ individual) (NN animal)) (NN basis))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT This) (NN type)) (PP (IN of) (NP (NN approach)))) (VP (MD could) (VP (VB be) (VP (VBN exploited) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (NN future) (NNS studies)) (PP (IN of) (NP (NML (NN γ2) (NN receptor)) (NN function)))))))) (. .)) )
( (S (ADVP (RB Lastly)) (, ,) (NP-SBJ (NP (NNS decreases)) (PP (IN in) (NP (NN benzodiazepine) (NN binding)))) (VP (MD may) (RB not) (ADVP-MNR (RB directly)) (VP (VB translate) (PP (IN into) (NP (NP (NNS changes)) (PP (IN in) (NP (ADJP (FW in) (FW vivo)) (NN insensitivity))))))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (PP-LOC (IN in) (NP (ADJP (NN α1) (JJ null)) (NNS mice))) (, ,) (NP-SBJ (NP (NNS changes)) (PP (IN in) (NP (NN benzodiazepine) (NN binding)))) (VP (VP (VBD did) (RB not) (VP (VB change) (NP (NP (NML (JJ whole) (NN animal)) (NN sensitivity)) (PP (IN to) (NP (NN midazolam)))))) (CC but) (VP (VBD increased) (NP (NP (NN sensitivity)) (PP (IN to) (NP (NN diazepam)))) (PRN (-LRB- [) (NP (CD 40) (, ,) (CD 41)) (-RRB- ])))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (PP-LOC (IN in) (NP (NP (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (ADVP (RB selectively)) (VP (VBP lack) (NP (NP (DT the) (JJ long) (NN splice) (NN variant)) (PP (IN of) (NP (NN γ2))))))))) (, ,) (S (S (NP-SBJ-1 (NP (NN affinity)) (PP (IN for) (NP (NN benzodiazepine) (NN site) (NNS ligands)))) (VP (VBZ is) (VP (VBN increased) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-3 (NP (JJ behavioral) (NN response)) (PP (IN to) (NP (NP (DT the) (JJ sedative) (NNS effects)) (PP (IN of) (NP (NN midazolam) (CC and) (NN zolpidem)))))) (VP (VBZ is) (RB also) (VP (VBN increased) (NP-3 (-NONE- *)) (PRN (-LRB- [) (NP (CD 42)) (-RRB- ])))))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (PP-LOC (IN in) (NP (NP (NNS mice)) (VP (VBG lacking) (NP (DT the) (NN β3) (NN subunit))))) (, ,) (NP-SBJ-1 (NP (VBN decreased) (NN benzodiazepine) (NN binding)) (CC and) (NP (VBN decreased) (NML (NML (JJ whole) (NN animal)) (NN midazolam)) (NN sensitivity))) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 43)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (JJ Further) (NN study)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB examine) (NP (DT these) (NNS possibilities))))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN produced) (NP (NP (DT a) (JJ novel) (ADJP (RB genetically) (VBN engineered)) (NN mouse) (NN line)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VP (VBZ exhibits) (NP (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN γ2) (NN mRNA) (NNS levels)))) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (RB highly) (JJ variable)) (PP (IN between) (NP (NNS mice))) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN range)) (NP-PRD (NP (QP (CD 10) (SYM –) (CD 95)) (NN %)) (PP (IN of) (NP (NN control))))) (-RRB- -RRB-))))))) (CC but) (VP (VBZ averages) (NP (NP (QP (SYM ~) (CD 35)) (NN %)) (PP (IN of) (NP (NN control) (NNS levels))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NML (NN γ2) (NN knockdown)) (NNS mice)) (VP (VP (VBP are) (ADJP-PRD (JJ viable))) (CC and) (VP (VBP have) (NP (VBN enhanced) (ADJP (NN anxiety) (HYPH -) (JJ like)) (JJ behavioral) (NNS abnormalities)))) (. .)) )
( (S (ADVP (RB Surprising)) (, ,) (NP-SBJ (DT these) (NNS mice)) (VP (VBP are) (ADVP (RB normally)) (ADJP-PRD (JJ sensitive) (PP (IN to) (NP (NP (DT the) (JJ hypnotic) (NNS effects)) (PP (IN of) (NP (NN benzodiazepine) (NN site) (NNS ligands))))))) (. .)) )
( (S (ADVP (RB Lastly)) (, ,) (NP-SBJ-1 (DT this) (JJ novel) (ADJP (RB genetically) (VBN engineered)) (NN mouse) (NN line)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (ADVP (RB easily)) (VP (VBN converted) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT a) (NML (NN γ2) (JJ global) (NN knockout)) (NN mouse) (NN line))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (ADVP (RB simply)) (VP (VBG crossing) (PP (IN to) (NP (DT a) (ADJP (NN cre) (HYPH -) (VBG expressing)) (NML (JJ global) (NN deleter)) (JJ transgenic) (NN mouse) (NN line))))))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (ADJP (RB genetically) (VBN altered)) (NNS mice))))) )
( (S (NP-SBJ-1 (NP (DT A) (NML (NML (NML (CD 13.6) (NN kB)) (NN BglII) (NN Strain) (CD 129) (HYPH /) (NN SvJ)) (NN mouse) (JJ genomic) (NN DNA)) (NN fragment)) (VP (VBG containing) (NP (NP (NNS Exons) (NML (NML (CD 8)) (PP (SYM –) (NP (CD 10))))) (PP (IN of) (NP (DT the) (NML (NN GABAA) (HYPH -) (NN R)) (NN γ2) (NN gene)))))) (VP (VBD was) (VP (VBN subcloned) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT a) (NN P1) (NN phage) (NN clone))) (PRN (-LRB- -LRB-) (NP (NP (NNP Genome) (NNP Systems)) (, ,) (NP-LOC (NNP St.) (NNP Louis)) (, ,) (NP-LOC (NNP MO))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT An) (NN oligonucleotide)) (VP (VBG containing) (NP (NP (DT a) (NN loxP) (NN site)) (CC and) (NP (DT an) (NN EcoRV) (NN site))))) (VP (VBD was) (VP (VBN inserted) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (NP (DT a) (NN NcoI) (NN site)) (NP-LOC (NP (NML (CD 647) (NN bp)) (CD 5) (SYM ')) (PP (IN to) (NP (NN Exon) (CD 8)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (VBN blunted) (NN fragment)) (VP (VBG containing) (NP (NP (NP (DT a) (NML (NN NEO) (NN resistance)) (NN gene)) (PP (IN with) (NP (NP (NML (NN PGK) (HYPH -) (CD 1)) (NML (NN promoter) (CC and) (NN polyadenylation)) (NNS signals)) (-LRB- -LRB-) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN from) (NP (NN pPNT))) (PRN (-LRB- [) (NP (CD 44)) (-RRB- ])))))) (-RRB- -RRB-) (VP (VBN fused) (NP (-NONE- *)) (PP (IN with) (NP (DT a) (NN loxP) (NN site))))))) (VP (VBD was) (VP (VBN inserted) (NP-1 (-NONE- *)) (PP-DIR (IN into) (NP (NP (DT a) (NN HincII) (NN site)) (NP-LOC (NP (NML (CD 855) (NN bp)) (CD 3) (SYM ')) (PP (IN of) (NP (NN Exon) (CD 8)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN NEO) (NN gene)) (VP (VBD was) (VP (VBN inserted) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT the) (JJ opposite) (NN orientation)) (PP (IN to) (NP (NN γ2) (NN transcription))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (ADJP (NN PGK) (VBN driven)) (NML (NN thymidine) (NN kinase)) (NN expression) (NN cassette)) (-LRB- -LRB-) (VP (VBN obtained) (NP (-NONE- *)) (PP (IN from) (NP (NN pPNT) (PRN (-LRB- [) (NP (CD 44)) (-RRB- ]))))) (-RRB- -RRB-)) (VP (VBD was) (ADVP-TMP (RB then)) (VP (VBN cloned) (NP-1 (-NONE- *)) (NP-LOC (NP (CD 3) (SYM ')) (PP (IN to) (NP (DT the) (NN γ2) (JJ genomic) (NN DNA)))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN targeting) (NN construct)) (VP (VBD was) (VP (VP (VP (VBN linearized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN SalI)))) (CC and) (VP (VBN electroporated) (NP-1 (-NONE- *)) (PP-LOC (IN into) (NP (NN R1) (JJ embryonic) (NN stem) (NNS cells) (PRN (-LRB- [) (NP (CD 45)) (-RRB- ])))))) (PP-TMP (VBG following) (NP (ADJP (RB previously) (VBN described)) (NNS procedures))) (PRN (-LRB- [) (NP (CD 46)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (ADJP (NP (NP (NN G418) (PRN (-LRB- -LRB-) (NP (NP (CD 270) (NN μg)) (PP (SYM /) (NP (NN ml)))) (: ;) (NP (NP (NNP Life) (NNP Technologies)) (, ,) (NP-LOC (NNP Gaithersburg)) (, ,) (NP-LOC (NNP MD))) (-RRB- -RRB-))) (CC and) (NP (NN gancyclovir) (PRN (-LRB- -LRB-) (NP (CD 2) (NN μM)) (: ;) (NP (NNP Sigma)) (-RRB- -RRB-)))) (JJ resistant)) (NNS cells)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP (IN for) (NP (NN gene) (NN targeting))) (PP-MNR (IN by) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (ADJP (NN BglII) (VBN digested)) (JJ genomic) (NN DNA))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Fragments)) (VP (VBD were) (VP (VBN hybridized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NML (CD 5) (SYM ')) (NN probe)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD was) (ADJP-PRD (JJ external) (PP (IN to) (NP (DT the) (VBG targeting) (NN construct)))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Fig.) (CD 1)))) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Proper) (NN targeting)) (PP (IN of) (NP (DT the) (NN γ2) (NN locus)))) (VP (VBD was) (VP (VBN confirmed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (ADJP (NP (NN EcoRV) (CC and) (NN SstI)) (VBN digested)) (NN DNA))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Additional) (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN with) (NP (NP (NP (NNS probes)) (UCP (PP (IN to) (NP (DT the) (NN neomycin) (NN cassette))) (CC or) (ADJP (JJ internal) (PP (IN to) (NP (NP (DT the) (NML (CD 3) (SYM ')) (NN arm)) (PP (IN of) (NP (DT the) (NN targeting) (NN vector)))))))) (-LRB- -LRB-) (PP (IN with) (NP (QP (CD 1) (SYM –) (CD 3)) (NN restriction) (NNS enzymes))))) (-RRB- -RRB-)) (VP (VBD were) (RB also) (VP (VBN conducted) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS results)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT All) (NNS results)) (VP (VBD were) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (DT a) (ADJP (RB correctly) (VBN targeted)) (NN γ2) (NN locus))))) (. .)) )
( (S (NP-SBJ-1 (NP (CD Two) (ADJP (RB correctly) (VBN targeted)) (NML (JJ embryonic) (NN stem) (NN cell)) (NNS clones)) (-LRB- -LRB-) (NP (NN 26C8) (CC and) (NN 26L6))) (-RRB- -RRB-) (VP (VBD were) (VP (VBN microinjected) (NP-1 (-NONE- *)) (PP-LOC (IN into) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS blastocysts))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (JJ chimeric) (NNS mice))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Male) (NNS chimeras)) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS females))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Agouti) (NN offspring)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT the) (VBN targeted) (NN allele))) (PRN (-LRB- -LRB-) (NP (NN F) (HYPH /) (SYM +)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN interbred) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (NP (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (NP-PRD (UCP (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (ADJP (JJ heterozygous)) (, ,) (CC or) (ADJP (JJ homozygous))) (NNS mutants) (PRN (-LRB- -LRB-) (NP (NN F) (HYPH /) (NN F)) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NNS mice)) (VP (VBN used) (NP (-NONE- *)) (PP (IN in) (NP (NP (NNS studies)) (VP (VBN reported) (NP (-NONE- *)) (ADVP (RB here))))))) (VP (VBD were) (VP (VBN derived) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NML (NN 26L6) (NN ES)) (NN cell) (NN clone))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS mice)) (VP (VBD were) (VP (VBN housed) (NP-1 (-NONE- *)) (PP (IN under) (NP (NP (NNS conditions)) (PP (IN of) (NP (NP (NP (NP (NNS lights)) (ADJP (JJ on))) (PP-TMP (IN at) (NP (CD 07:00)))) (CC and) (NP (NP (NP (NNS lights)) (ADJP (JJ off))) (PP-TMP (IN at) (NP (CD 19:00)))))))))) (. .)) )
( (HEADING (NP (NML (NNP Northern) (NN blot)) (NN analysis))) )
( (S (NP-SBJ-1 (ADJP (NP (QP (CD Ten) (IN to) (CD fourteen)) (NN week)) (JJ old)) (NNS mice)) (VP (VBD were) (VP (VBN sacrificed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ cervical) (NN dislocation))))) (. .)) )
( (S (NP-SBJ-1 (NN RNA)) (VP (VBD was) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (JJ whole) (NN brain))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN Trizol) (NN reagent) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NP (CD 20) (NN μg)) (PP (IN of) (NP (JJ total) (NN RNA)))) (VP (VBD was) (VP (VP (VBN electrophoresed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT a) (NML (NML (NML (CD 1.9) (NN %)) (NN formaldehyde)) (HYPH /) (NML (NML (CD 1) (NN %)) (NN agarose))) (NN gel)))) (CC and) (VP (VBD blotted) (NP-1 (-NONE- *)) (PP-LOC (IN onto) (NP (NN Hybond) (HYPH -) (NN N) (PRN (-LRB- -LRB-) (NP (NNP Amersham) (NNP Pharmacia)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Blots)) (VP (VBD were) (ADVP-TMP (RB first)) (VP (VP (VBN probed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (ADJP (NN 32P) (HYPH -) (VBN labeled)) (NN γ2) (NN cDNA) (NN probe)))) (VP (ADVP-TMP (RB then)) (VBN re-hybrizided) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN control) (JJ human) (NML (NN β) (HYPH -) (NN actin)) (NN probe) (PRN (-LRB- -LRB-) (NP (NNP Clontech)) (-RRB- -RRB-))))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Autoradiographs)) (VP (VBD were) (ADVP-MNR (RB digitally)) (VP (VBN photographed) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2 (NN band) (NNS densities)) (VP (VBD were) (VP (VBN measured) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NNP Kodak) (NNP 1D) (NN Image) (NN Analysis)) (NN Software))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Ratio)) (PP (IN between) (NP (NP (NN density)) (PP (IN of) (NP (NP (NN γ2) (NN hybridization)) (CC versus) (NP (NN actin) (NN hybridization))))))) (VP (VBD was) (VP (VBN recorded) (NP-1 (-NONE- *)))) (. .)) )
( (HEADING (NP (NN Immunocytochemistry))) )
( (S (NP-SBJ-1 (DT The) (NN procedure)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (ADVP-LOC (RB elsewhere)) (PRN (-LRB- [) (NP (CD 47)) (-RRB- ]))))) (. .)) )
( (S (ADVP-TMP (RB Briefly)) (, ,) (NP-SBJ-1 (UCP (NML (JJ wild) (NN type)) (CC and) (ADJP (JJ homozygous))) (NNS mutants)) (VP (VBD were) (VP (VP (ADVP (RB deeply)) (VBN anesthetized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN Avertin)))) (CC and) (VP (VP (ADVP (RB transcardially)) (VBN perfused) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP=2 (NML (NN Dextran) (HYPH -) (NN Phosphate)) (NN Buffer) (PRN (-LRB- -LRB-) (NP (NN PB)) (-RRB- -RRB-))))) (VP (ADVP-TMP (RB then)) (NP=2 (NP (NN fixative)) (VP (VBG consisting) (PP (IN of) (NP (NP (NML (NN 0.01M) (NN periodate)) (HYPH /) (NML (NN 0.075M) (NN lysine)) (HYPH /) (NML (NML (CD 4) (NN %)) (NN paraformaldehyde))) (PP-LOC (IN in) (NP (NP (NN 0.1M) (NN PB)) (-LRB- -LRB-) (NP-ADV (NN pH) (CD 7.4)) (-RRB- -RRB-))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS brains)) (VP (VBD were) (VP (VP (VBN frozen) (NP-1 (-NONE- *))) (CC and) (VP (VBN sliced) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (JJ parasaggital) (NNS sections) (PRN (-LRB- -LRB-) (NP (CD 25) (NN μm)) (-RRB- -RRB-)))) (PP-MNR (IN with) (NP (DT a) (JJ freezing) (NN microtome)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Slices)) (VP (VBD were) (VP (VBN incubated) (NP-1 (-NONE- *)) (ADVP-TMP (RB overnight)) (PP (IN at) (NP (CD 4) (NN °C))) (PP (IN with) (NP (NP (ADJP (NN affinity) (HYPH -) (VBN purified)) (NN rabbit) (JJ anti-γ2) (PRN (-LRB- [) (NP (CD 48) (, ,) (CD 49)) (-RRB- ]))) (PP-LOC (IN in) (NP (NP (NN 0.1M) (NN PB)) (-LRB- -LRB-) (NP-ADV (NN pH) (CD 7.4)) (-RRB- -RRB-) (PP (IN with) (NP (NML (CD 0.3) (NN %)) (NN Triton) (NN X) (HYPH -) (NN 100))))))) (, ,) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM :) (NP (CD 100))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS sections)) (VP (VBD were) (VP (VBN processed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT an) (NML (NN avidin) (HYPH -) (NN biotin) (HYPH -) (NN peroxidase)) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP Vectastain) (NNP Elite)) (: ;) (NP (NP (NNP Novocastra)) (, ,) (NP-LOC (NNP Burlingame)) (, ,) (NP-LOC (NNP CA))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NN Peroxidase) (NN reaction)) (VP (VBD was) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-MNR (IN with) (NP (NML (NML (CD 3)) (HYPH -) (NML (CD 3) (SYM '))) (NN diaminobenzidine) (NN tetrahydrochloride))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (NP (NN cobalt) (NN chloride)) (CC and) (NP (NN nickel) (NN ammonium) (NN sulfate))) (PP (IN as) (NP (NNS chromogens)))) (CC and) (NP (NP (NN hydrogen) (NN peroxide)) (PP (IN as) (NP (NN oxidant)))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Controls)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (CC either) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG omitting) (NP (DT the) (JJ primary) (NN antibody))))) (CC or) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG incubating) (NP (DT the) (JJ primary) (NN antibody)) (PP (IN with) (NP (DT the) (VBG corresponding) (NN peptide))))))) (PRN (-LRB- [) (NP (CD 50)) (-RRB- ])))) (. .)) )
( (HEADING (NP (NN Pharmacology))) )
( (S (S (NP-SBJ-1 (ADJP (NP (CD Eight) (HYPH -) (NN week)) (HYPH -) (JJ old)) (NNS mice)) (VP (VBD were) (VP (VBN sacrificed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN decapitation)))))) (CC and) (S (NP-SBJ-2 (JJ whole) (NNS brains)) (VP (VBD were) (ADVP-TMP (RB rapidly)) (VP (VP (VBN dissected) (NP-2 (-NONE- *)) (PRT (RP out))) (CC and) (VP (VBN frozen) (NP-2 (-NONE- *)) (PP-MNR (IN on) (NP (JJ dry) (NN ice))))))) (. .)) )
( (S (PP (IN For) (NP (NN autoradiography))) (, ,) (NP-SBJ-1 (NML (CD 14) (HYPH -) (NN μm)) (JJ horizontal) (JJ serial) (NN cryostat) (NNS sections)) (VP (VBD were) (VP (VP (VBN cut) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (CD 5) (NN mouse) (NNS brains)) (PP (IN of) (NP (DT each) (NN genotype)))))) (, ,) (VP (NN thaw) (HYPH -) (VBN mounted) (NP-1 (-NONE- *)) (PP-LOC (IN onto) (NP (ADJP (NN gelatin) (HYPH -) (VBN coated)) (NN object) (NNS glasses)))) (, ,) (CC and) (VP (VBD stored) (NP-1 (-NONE- *)) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (ADJP-PRD (VBN frozen))) (PP-MNR (IN under) (NP (NN desiccant))) (PP (IN at) (NP (QP (SYM -) (CD 20)) (NN °C)))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS experiments)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP (IN in) (NP (JJ parallel) (NN fashion))) (PP (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (NN mouse) (NNS lines))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG eliminating) (NP (NP (DT any) (NML (NML (NN day)) (HYPH -) (PP (IN to) (HYPH -) (NP (NN day)))) (NN variation)) (PP (IN between) (NP (DT the) (NNS assays)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ autoradiographic) (NNS procedures)) (PP (IN for) (NP (NP (JJ regional) (NN localization)) (PP (IN of) (NP (NML (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro) (CD 15) (HYPH -) (CD 4513)) (, ,) (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol)) (, ,) (CC and) (NML (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS))) (NN binding)))))) (VP (VBD were) (SBAR-PRD (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN described) (NP-1 (-NONE- *)) (PP (IN in) (-LRB- [) (NP (CD 51))))))) (-RRB- ]) (. .)) )
( (S (ADVP-TMP (RB Briefly)) (, ,) (NP-SBJ-1 (NNS sections)) (VP (VBD were) (VP (VP (VBN preincubated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT an) (NML (NN ice) (HYPH -) (NN water)) (NN bath))) (PP-TMP (IN for) (NP (CD 15) (NN min))) (PP-LOC=2 (IN in) (NP (NP (NP (NML (CD 50) (NN mM)) (NN Tris) (HYPH -) (NN HCl)) (-LRB- -LRB-) (NP-ADV (NN pH) (CD 7.4)) (-RRB- -RRB-)) (VP (VBN supplemented) (NP (-NONE- *)) (PP (IN with) (NP (NML (CD 120) (NN mM)) (NN NaCl)))))) (PP=3 (IN in) (NP (DT the) (NML (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro) (CD 15) (HYPH -) (CD 4513)) (CC and) (NML (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS))) (JJ autoradiographic) (NNS assays)))) (, ,) (CC and) (VP (PP-LOC=2 (IN in) (NP (NP (NML (CD 0.31) (NN M)) (NN Tris) (HYPH -) (NN citrate)) (-LRB- -LRB-) (NP-ADV (NN pH) (CD 7.1)) (-RRB- -RRB-))) (PP=3 (IN in) (NP (DT the) (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol)) (NN assay)))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS radioligands)) (VP (VBD were) (VP (VBN purchased) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NNP Perkin) (NNP Elmer) (NNP Life) (NNPS Sciences)) (, ,) (ADJP (NNP Inc.)) (PRN (-LRB- -LRB-) (NP (NP (NNP Boston)) (, ,) (NP-LOC (NNP MA)) (, ,) (NP-LOC (NNP USA))) (-RRB- -RRB-)))))) (. .)) )
( (S (S (NP-SBJ-1=2 (NP (DT The) (JJ final) (NN incubation)) (PP-LOC (IN in) (NP (JJ respective) (NN preincubation) (NN buffer)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (CD 6) (NN nM)) (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS))) (PP=3 (IN at) (NP (NN room) (NN temperature))) (PP-TMP=4 (IN for) (NP (CD 90) (NNS min)))))) (, ,) (S (NP-SBJ=2 (NP (NNS assays)) (PP (IN with) (NP (NML (CD 10) (NN nM)) (-LRB- [) (NN 3H) (-RRB- ]) (NN muscimol)))) (PP=3 (IN at) (NP (QP (CD 0) (SYM –) (CD 4)) (NN °C))) (PP-TMP=4 (IN for) (NP (CD 30) (NN min)))) (, ,) (CC and) (S (NP-SBJ=2 (NP (NNS assays)) (PP (IN with) (NP (NML (CD 10) (NN nM)) (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro) (CD 15) (HYPH -) (CD 4513)))) (PP (IN in) (NP (NP (DT the) (NML (NN presence) (CC and) (NN absence))) (PP (IN of) (NP (NML (CD 100) (NN μM)) (NN diazepam) (PRN (-LRB- -LRB-) (NP (NP (NNP Orion) (NNP Pharma)) (, ,) (NP-LOC (NNP Espoo)) (, ,) (NP-LOC (NNP Finland))) (-RRB- -RRB-)))))) (PP=3 (IN at) (NP (QP (CD 0) (SYM –) (CD 4)) (NN °C))) (PP-TMP=4 (IN for) (NP (CD 60) (NN min)))) (. .)) )
( (S (PP-TMP (IN After) (NP (NN incubation))) (, ,) (NP-SBJ-1 (NNS sections)) (VP (VBD were) (VP (VBN washed) (NP-1 (-NONE- *)) (NP-TMP (NP (NML (CD 3) (SYM ×) (CD 15)) (NN s)) (CC or) (NP (NML (CD 2) (SYM ×) (CD 30)) (NN s))) (PP-LOC (IN in) (NP (DT an) (NML (NN ice) (HYPH -) (NN cold)) (NN incubation) (NN buffer))) (PP (PP (IN in) (NP (NP (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS)) (CC and) (NP (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro) (CD 15) (HYPH -) (CD 4513)))) (CC or) (PP (IN in) (NP (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol)) (NN assay)))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ-1 (NNS Sections)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VP (VBN dipped) (NP-1 (-NONE- *)) (PP-LOC (IN into) (NP (JJ distilled) (NN water)))) (, ,) (VP (NN air) (HYPH -) (VBN dried) (NP-1 (-NONE- *)) (PP-MNR (IN under) (NP (DT a) (NN fan))) (PP (IN at) (NP (NN room) (NN temperature)))) (, ,) (CC and) (VP (VBN exposed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN plastic) (NML (NML (-LRB- [) (CD 3H) (-RRB- ]) (HYPH -) (CC or) (-LRB- [) (CD 14C) (-RRB- ])) (HYPH -) (JJ methacrylate)) (NNS standards))) (PP (IN to) (NP (NML (NNP Kodak) (NNP Biomax)) (NNP MR) (NNS films))) (PP-TMP (IN for) (NP (QP (CD 1) (IN to) (CD 8)) (NNS weeks)))))) (. .)) )
( (S (NP-SBJ-1 (JJ Nonspecific) (NN binding)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NML (CD 10) (NN μM)) (NN flumazenil) (PRN (-LRB- -LRB-) (NP (NP (NNP Hoffmann) (HYPH -) (NNP La) (NNP Roche)) (, ,) (NP-LOC (NNP Basel)) (, ,) (NP-LOC (NNP Switzerland))) (-RRB- -RRB-))) (, ,) (NP (NML (CD 100) (NN μM)) (NN picrotoxinin) (PRN (-LRB- -LRB-) (NP (NNP Sigma)) (-RRB- -RRB-))) (CC and) (NP (NML (CD 100) (NN μM)) (NN GABA) (PRN (-LRB- -LRB-) (NP (NNP Sigma)) (-RRB- -RRB-))))) (PP (IN in) (NP (NML (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro) (CD 15) (HYPH -) (CD 4513)) (, ,) (NML (-LRB- [) (NN 35S) (-RRB- ]) (NN TBPS)) (CC and) (NML (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol))) (NNS assays))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Binding) (NNS densities)) (PP-LOC (IN in) (NP (DT the) (JJ relevant) (NN brain) (NNS areas)))) (VP (VBD were) (VP (VP (VBN quantitated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (NN MCID) (NN M5) (HYPH -) (VBG imaging)) (NN software) (PRN (-LRB- -LRB-) (NP (NP (NNP Imaging) (NNP Research) (NNP Inc.)) (, ,) (NP-LOC (NNP Ontario)) (, ,) (NP-LOC (NNP Canada))) (-RRB- -RRB-))))) (CC and) (VP (VBN converted) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NML (NML (NN nCi)) (PP (SYM /) (NP (NN mg))) (PRN (-LRB- -LRB-) (PP (IN for) (NP (CD 3H))) (-RRB- -RRB-))) (CC or) (NML (NML (NN nCi)) (PP (SYM /) (NP (NN g))) (PRN (-LRB- -LRB-) (PP (IN for) (NP (NN 35S))) (-RRB- -RRB-)))) (NN radioactivity) (NNS values))) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT the) (ADJP (RB simultaneously) (VBN exposed)) (NNS standards)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS concentrations)) (PP (IN of) (NP (NP (-LRB- [) (CD 3H) (-RRB- ]) (NN muscimol) (PRN (-LRB- -LRB-) (NP (CD 10) (NN nM)) (-RRB- -RRB-))) (CC and) (NP (-LRB- [) (CD 3H) (-RRB- ]) (NN Ro) (CD 15) (HYPH -) (CD 4513) (PRN (-LRB- -LRB-) (NP (CD 10) (NN nM)) (-RRB- -RRB-)))))) (VP (VBD were) (ADJP-PRD (ADJP (JJR greater) (PP (IN than) (NP-2 (-NONE- *RNR*)))) (CC or) (ADJP (JJ equal) (PP (IN to) (NP-2 (-NONE- *RNR*)))) (NP-2 (NP (DT the) (NN dissociation) (NNS constants)) (PP (IN for) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (ADJP (JJ recombinant) (CC and) (JJ native)) (NN GABAA) (NNS receptors))))))) (PRN (-LRB- [) (NP (CD 8)) (, ,) (NP (NP (CD 52)) (PP (SYM -) (NP (CD 54)))) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (DT the) (JJ autoradiographic) (NNS images)) (VP (MD should) (VP (VB represent) (NP (NP (DT the) (NML (NML (NN density)) (CONJP (RB rather) (IN than)) (NML (NN affinity)))) (PP (IN of) (NP (NN binding) (NNS sites)))))) (. .)) )
( (HEADING (NP (JJ Hypnotic) (NN sensitivity))) )
( (S (NP-SBJ-1 (ADJP (NN Drug) (VBN induced)) (NN hypnosis)) (VP (VBD was) (VP (VBN assessed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG measuring) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN righting) (NN reflex)))))) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (JJ various) (ADJP (JJ sedative) (HYPH /) (JJ hypnotic)) (NNS drugs)))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Diazepam) (PRN (-LRB- -LRB-) (NP (NP (CD 25) (NN mg)) (PP (SYM /) (NP (NN kg)))) (: ;) (NP (NNP Sigma)) (-RRB- -RRB-))) (, ,) (NP (NN midazolam) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 45) (NN mg)) (PP (SYM /) (NP (NN kg)))) (CC and) (NP (NP (CD 75) (NN mg)) (PP (SYM /) (NP (NN kg))))) (: ;) (NP (NP (NNP ESI) (NNP Lederle)) (, ,) (NP-LOC (NNP Philadelphia)) (, ,) (NP-LOC (NNP PA))) (-RRB- -RRB-))) (, ,) (NP (NN pentobarbital) (PRN (-LRB- -LRB-) (NP (NP (CD 45) (NN mg)) (PP (SYM /) (NP (NN kg)))) (: ;) (NP (NP (NNP Abbott)) (, ,) (NP-LOC (NNP Chicago)) (, ,) (NP-LOC (NNP IL))) (-RRB- -RRB-))) (, ,) (NP (NN zolpidem) (PRN (-LRB- -LRB-) (NP (NP (CD 60) (NN mg)) (PP (SYM /) (NP (NN kg)))) (: ;) (NP (NP (NNP Searle)) (, ,) (NP-LOC (NNP Malvern)) (, ,) (NP-LOC (NNP PA))) (-RRB- -RRB-))) (CC or) (NP (NN ethanol) (PRN (-LRB- -LRB-) (NP (NP (CD 3.5) (NN mg)) (PP (SYM /) (NP (NN kg)))) (: ;) (NP (NP (NNP Pharmco)) (, ,) (NP-LOC (NNP Brookfield)) (, ,) (NP-LOC (NNP CT))) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN administered) (NP-1 (-NONE- *)) (ADVP-MNR (RB intraperitoneally)) (PP (IN to) (NP (UCP (NML (JJ wild) (NN type)) (CC and) (ADJP (JJ homozygous))) (NNS mutants))))) (. .)) )
( (S (NP-SBJ-1 (NNS Drugs)) (VP (VBD were) (VP (VBN diluted) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN saline))) (SBAR-MNR (JJ such) (IN that) (S (NP-SBJ (DT the) (NN injection) (NN volume)) (VP (VBD was) (NP-PRD (NP (CD 20) (NN μL)) (PP (IN per) (NP (NN gram) (NN body) (NN weight))))))))) (. .)) )
( (S (PP-TMP (IN After) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG losing) (NP (DT the) (NN righting) (NN reflex))))) (, ,) (S (S (NP-SBJ-2 (NNS mice)) (VP (VBD were) (VP (VBN placed) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (DT a) (JJ plastic) (ADJP (NN V) (HYPH -) (VBN shaped)) (NN trough)))))) (CC and) (S (NP-SBJ-1 (DT the) (NN time)) (VP (VBD was) (VP (VBN recorded) (NP-1 (-NONE- *)))))) (. .)) )
( (S (SBAR-TMP (WHADVP-1 (WRB When)) (S (NP-SBJ-2 (DT the) (NN mouse)) (VP (VBD was) (ADJP-PRD (JJ able) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB right) (NP (PRP itself)) (NP-TMP (CD three) (NNS times)) (PP-TMP (IN in) (NP (CD 30) (NN s))))))) (ADVP-TMP-1 (-NONE- *T*))))) (, ,) (NP-SBJ (NP (DT the) (NN measure)) (PP (IN of) (NP (JJ hypnotic) (NN effect)))) (VP (VBD was) (ADVP-PRD (RB over))) (. .)) )
( (S (NP-SBJ-1 (NN Body) (NN temperature)) (VP (VBD was) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN aid)) (PP (IN of) (NP (DT a) (NN heat) (NN lamp))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Assays)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NP (DT a) (JJ blinded) (NN manner)) (PP (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (NN genotype))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Effect)) (PP (IN of) (NP (NN genotype))) (PP (IN on) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN righting) (NN reflex)))))))) (VP (VBD was) (VP (VBN compared) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN Student) (POS 's)) (NN t) (HYPH -) (NN test)))))) (. .)) )
( (HEADING (NP (NML (VBN Elevated) (NN plus) (HYPH -) (NN maze)) (NN test))) )
( (S (NP-SBJ-1 (JJ Basal) (ADJP (NN anxiety) (HYPH -) (JJ like)) (NN behavior)) (VP (VBD was) (VP (VBN tested) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (VBN elevated) (NN plus) (HYPH -) (NN maze)))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS mice)) (VP (VP (VBD were) (NP-PRD (NP (QP (IN between) (CD 7) (CC and) (CD 9)) (NNS weeks)) (PP (IN of) (NP (NN age))))) (CC and) (VP (VBD were) (VP (VBN tested) (NP-1 (-NONE- *)) (PP-TMP (IN between) (NP (NP (CD 09:00)) (CC and) (NP (CD 11:00))))))) (. .)) )
( (S (NP-SBJ-1 (DT Each) (NN mouse)) (VP (VBD was) (VP (VP (VBN placed) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NP (DT the) (JJ central) (NN platform)) (PP (IN of) (NP (DT the) (NN maze))))) (, ,) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBG facing) (NP (DT an) (JJ open) (NN arm))))) (CC and) (VP (VBN allowed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (ADVP-MNR (RB freely)) (VP (VB explore) (NP (DT the) (NN maze)) (PP-TMP (IN for) (NP (CD 5) (NN min))) (PP (IN under) (NP (JJ ambient) (NN room) (NN light))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (NML (JJ Open) (HYPH -) (NN arm)) (CC and) (NML (JJ closed) (HYPH -) (NN arm))) (NNS entries)) (CC and) (NP (NP (DT the) (JJ cumulative) (NN time)) (VP (VBN spent) (NP (-NONE- *)) (PP (IN on) (NP (DT the) (ADJP (JJ open) (CC and) (JJ closed)) (NNS arms)))))) (VP (VBD was) (VP (VBN recorded) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT A) (NN mouse)) (VP (VBD was) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (PP-LOC-PRD (PP (IN on) (NP (DT the) (JJ central) (NN platform))) (CC or) (PP (IN on) (NP (DT an) (NN arm))))))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (DT all) (CD four) (NNS paws)) (VP (VBD were) (PP-LOC-PRD (IN within) (NP (PRP$ its) (NN perimeter))) (ADVP-TMP-2 (-NONE- *T*))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NML (NN percent) (NML (JJ open) (HYPH -) (NN arm)) (NNS entries)) (, ,) (NML (NML (JJ total) (NN number)) (PP (IN of) (NP (NNS entries)))) (, ,) (CC and) (NML (NML (NN percent) (NN time)) (PP-LOC (IN in) (NP (JJ open) (HYPH -) (NNS arms)))))) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (NNS Data)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (CD one) (HYPH -) (NN way)) (NN ANOVA)))))) (. .)) )
( (HEADING (NP (VBN Forced) (NN exploration))) )
( (S (NP-SBJ-1 (NP (JJ Basal) (NN motor) (NN activity)) (PP (IN of) (NP (NNS mice)))) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (VBN forced) (NN exploration)) (NN test)))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (NP (QP (CD 8) (SYM –) (CD 10)) (NN week)) (JJ old)) (NNS mice)) (VP (VBD were) (VP (VBN placed) (NP-1 (-NONE- *)) (PP-LOC (IN into) (NP (DT a) (VBN walled) (NN arena) (PRN (-LRB- -LRB-) (NP (NP (CD 43.2) (NN cm)) (PP (SYM ×) (NP (CD 43.2) (NN cm))) (PP (SYM ×) (NP (CD 30.5) (NN cm)))) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (CD 5) (NN min))))) (. .)) )
( (S (NP-SBJ-1 (NN Distance) (VBN traveled) (PRN (-LRB- -LRB-) (NP (NN cm)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN measured) (NP-1 (-NONE- *)) (ADVP-MNR (RB automatically)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT an) (NN Activity) (NN Monitor) (PRN (-LRB- -LRB-) (NP (NP (NNP Med) (NNPS Associates)) (, ,) (NP-LOC (NNP St.) (NNP Albans)) (, ,) (NP-LOC (NNP VT))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS tests)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-TMP (IN between) (NP (NP (CD 12:00)) (CC and) (NP (CD 15:00)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Effect)) (PP (IN of) (NP (NN genotype))) (PP (IN on) (NP (JJ basal) (NN motor) (NN activity)))) (VP (VBD was) (VP (VBN compared) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN Student) (POS 's)) (NN t) (HYPH -) (NN test)))))) (. .)) )
( (HEADING (NP (NP (NNS Authors) (POS ')) (NNS contributions))) )
( (S (NP-SBJ (NNP CPM) (CC and) (NNP ALD)) (VP (VBD carried) (PRT (RP out)) (NP (DT the) (JJ immunohistochemical) (NNS studies))) (. .)) )
( (S (NP-SBJ (NNP ERK)) (VP (VBD carried) (PRT (RP out)) (NP (DT the) (NML (NN ligand) (NN autoradiography)) (NNS studies))) (. .)) )
( (S (NP-SBJ-1 (DT All) (JJ other) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNP DC) (CC and) (NNP GEH))))) (. .)) )
( (S (NP-SBJ (DT All) (NNS authors)) (VP (VP (VBD contributed) (PP (IN to) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG composing) (CC and) (VBG editing) (NP (DT the) (NN manuscript)))))) (CC and) (VP (VBP have) (VP (VBN read) (CC and) (VBN approved) (NP (DT the) (JJ final) (NN version))))) (. .)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ-1 (NP (NNP Carolyn) (NNP Ferguson)) (CC and) (NP (NNP Ed) (NNP Mallick))) (VP (VBP are) (ADVP (RB gratefully)) (VP (VBN acknowledged) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (JJ superb) (JJ technical) (NN support))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN work)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNP NIH) (NNS grants) (NML (NN AA10422) (, ,) (NN GM52035) (, ,) (NN GM47818) (, ,) (NN NS039287))) (, ,) (NP (DT the) (NML (NNP Sigrid) (NNP Juselius)) (NNP Foundation)) (, ,) (CC and) (NP (NP (DT the) (NNP Academy)) (PP (IN of) (NP (NNP Finland)))))))) (. .)) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (CAPTION (NP (NP (NP (NN Gene) (NN targeting)) (PP (IN of) (NP (NP (DT the) (NN γ2) (NN subunit)) (PP (IN of) (NP (DT the) (NN GABAA) (HYPH -) (NN R)))))) (CC and) (NP (NP (NN development)) (PP (IN of) (NP (NML (NN γ2) (NN knockdown)) (NNS mice)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Targeting) (NN strategy)) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (NML (NN γ2) (NN knockdown)) (NNS mice)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (JJ Relevant) (NN region)) (PP (IN of) (NP (NP (JJ endogenous) (NN gene) (PRN (-LRB- -LRB-) (NP (SYM +)) (-RRB- -RRB-))) (, ,) (NP (NN targeting) (NN vector)) (, ,) (NP (ADJP (RB correctly) (VBN targeted)) (NN knockdown) (NN γ2) (PRN (-LRB- -LRB-) (NP (NN F)) (-RRB- -RRB-))) (, ,) (CC and) (NP (ADJP (NN cre) (HYPH -) (VBN recombined)) (NN knockout) (NNS alleles) (PRN (-LRB- -LRB-) (NP (NN f)) (-RRB- -RRB-)))))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (JJ Relative) (NNS locations)) (PP (IN of) (NP (NP (JJ relevant) (NN restriction) (NNS sites)) (, ,) (NP (NNS exons) (PRN (-LRB- -LRB-) (NP (VBN numbered) (JJ orange) (NNS boxes)) (-RRB- -RRB-))) (, ,) (NP (NN loxP) (NNS sites) (PRN (-LRB- -LRB-) (NP (JJ blue) (NNS triangles)) (-RRB- -RRB-))) (, ,) (NP (NN plasmid) (NN backbone) (PRN (-LRB- -LRB-) (NP (JJ wavy) (NN line)) (-RRB- -RRB-))) (, ,) (CC and) (NP (ADJP (ADJP (JJ positive) (PRN (-LRB- -LRB-) (NP (NN NEO)) (-RRB- -RRB-))) (CC and) (ADJP (JJ negative) (PRN (-LRB- -LRB-) (NP (NN PGK) (HYPH -) (NN TK)) (-RRB- -RRB-)))) (NN selection) (NNS cassettes))))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NML (NNP Southern) (NN Blot)) (NN analysis)) (PP (IN of) (NP (ADJP (NN BglII) (VBN digested)) (NN tail) (NNS DNAs))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Probe) (NN A)) (VP (VBZ hybridizes) (PP (IN to) (NP (NP (NP (DT a) (NML (CD 9.2) (NN kb)) (NN BglII) (NN fragment)) (PP (IN from) (NP (DT the) (NML (JJ wild) (NN type)) (JJ endogenous) (NN allele)))) (CC and) (NP (NP (DT a) (NML (CD 3.4) (NN kb)) (NN BglII) (NN fragment)) (PP (IN from) (NP (DT the) (VBN targeted) (NN allele))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (CAPTION (NP (NML (NNP Northern) (NN blot)) (NN analysis) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Sample) (NML (NNP northern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (NML (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (CC and) (NML (JJ homozygous) (NN knockdown) (PRN (-LRB- -LRB-) (NP (NN F) (HYPH /) (NN F)) (-RRB- -RRB-)))) (JJ adult) (NML (JJ whole) (NN brain)) (JJ total) (NN RNA)) (VP (VBN hybrizided) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT a) (NN γ2) (NN cDNA)) (CC or) (NP (DT a) (JJ human) (NML (NN β) (HYPH -) (NN actin)) (NN probe)))) (PP (IN as) (NP (DT a) (NN loading) (NN control)))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (JJ Densitometric) (NN analysis)) (PP (IN of) (NP (NNP northern) (NNS blots))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (NN ratio)) (PP (IN of) (NP (NN band) (NN density))) (PP (IN between) (NP (NML (NML (NN γ2)) (CC and) (NML (NN β) (HYPH -) (NN actin))) (NN hybridization))) (PP (IN for) (NP (NML (UCP (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 23)))) (-RRB- -RRB-))) (CC and) (ADJP (JJ homozygous))) (NN knockdown) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 36)))) (-RRB- -RRB-))) (NNS mice)))) (VP (VBD was) (VP (VBN plotted) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (PP-LOC (IN On) (NP (DT each) (JJ individual) (NN blot))) (, ,) (NP-SBJ-1 (NP (DT the) (NN ratio)) (PP (IN of) (NP (NML (JJ wild) (NN type)) (NN band) (NNS densities)))) (VP (VBD was) (VP (VP (VBN averaged) (NP-1 (-NONE- *))) (CC and) (VP (VBN normalized) (NP-1 (-NONE- *)) (PP (IN to) (NP (CD 100)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT All) (NNS samples)) (PP (IN on) (NP (DT each) (NN blot)))) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NN average)) (PP (IN of) (NP (NP (NML (JJ wild) (NN type)) (NN band) (NNS densities)) (PP-LOC (IN on) (NP (DT that) (NN blot))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT A) (NN total)) (PP (IN of) (NP (CD 4) (JJ different) (NNS blots)))) (VP (VBD were) (VP (VBN included) (NP-1 (-NONE- *)) (PP (IN in) (NP (DT this) (NN analysis))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (JJ horizontal) (NN bar)) (PP (IN in) (NP (DT each) (NN column)))) (VP (VBZ represents) (NP (NP (DT the) (NN mean)) (PP (IN for) (NP (DT that) (NN genotype))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (CAPTION (NP (NP (JJ Immunohistochemical) (NN distribution)) (PP (IN of) (NP (NP (NN γ2) (NN subunit)) (PP (IN of) (NP (DT the) (NN GABAA) (HYPH -) (NN R))))) (PP-LOC (IN in) (NP (NP (NNS sections)) (PP (IN from) (NP (JJ individual) (NML (UCP (NML (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (JJ wild) (NN type)) (CC and) (ADJP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (JJ homozygous))) (NN knockdown)) (NNS mice))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (NP (NP (DT the) (JJ high) (NN level)) (PP (IN of) (NP (NP (NN abundance)) (PP (IN of) (NP (NN γ2) (NN immunoreactivity))))) (PP-LOC (IN in) (NP (NP (NP (NP (JJ olfactory) (NN bulb)) (-LRB- -LRB-) (NP (NN OB)) (-RRB- -RRB-)) (, ,) (NP (NP (JJ cerebral) (NN cortex)) (-LRB- -LRB-) (NP (NN CC))) (-RRB- -RRB-) (, ,) (NP (NP (NN hippocampus)) (-LRB- -LRB-) (NP (NN HP))) (-RRB- -RRB-) (, ,) (NP (NP (NN substantia) (NN nigra)) (-LRB- -LRB-) (NP (NN SN))) (-RRB- -RRB-) (, ,) (CC and) (NP (NP (NN cerebellum)) (-LRB- -LRB-) (NP (NN CB)))) (-RRB- -RRB-) (PP (IN of) (NP (NML (JJ wild) (NN type)) (NNS samples)))))) (. .)))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT The) (NN amount)) (PP (IN of) (NP (NN γ2)))) (VP (VBZ is) (ADVP (RB variably)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (JJ many) (NN brain) (NNS regions)) (PP (IN of) (NP (DT the) (NN knockdown) (NNS samples))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (CAPTION (NP (NP (JJ Behavioral) (NN characterization)) (PP (IN of) (NP (NN knockdown) (NNS mice))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (SYM -) (LS C) (-RRB- -RRB-)) (VBN Elevated) (NN plus) (NN maze) (. .))) )
( (CAPTION (S (S (NP-SBJ (NN Knockdown) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (VP (VBD entered) (NP (JJ open) (NNS arms)) (UCP-TMP (ADVP (RBR less) (RB often)) (CC and) (PP (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-)) (IN for) (NP (JJR less) (NN time)))))) (, ,) (S (ADVP (RB however)) (, ,) (NP-SBJ (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)) (NP (JJ total) (NNS entries)) (PP (IN into) (NP (NNS arms)))) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN from) (NP (NML (JJ wild) (NN type)) (NNS mice)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ (NN Knockdown) (NNS mice)) (VP (VBD were) (ADVP (RB also)) (ADJP-PRD (RBR less) (JJ active)) (PP (IN in) (NP (DT the) (NML (VBN forced) (NN exploration)) (NN test)))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NNS bars)) (VP (VBP are) (NP-PRD (NNS means) (SYM ±) (NN SEM))) (. .))) )
( (CAPTION (S (S-FRM (NP-SBJ (NN *p)) (VP (SYM <) (NP (CD .01)))) (, ,) (S-FRM (NP-SBJ (NN **p)) (VP (SYM <) (NP (CD .001)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (CAPTION (NP (JJ Hypnotic) (NN sensitivity) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT No) (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (DT the) (JJ hypnotic) (NNS effects)) (PP (IN of) (NP (NN ethanol) (, ,) (NN pentobarbital) (, ,) (NN zolpidem) (, ,) (NN midazolam) (, ,) (CC or) (NN diazepam)))))) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NNS bars)) (VP (VBP are) (NP-PRD (NNS means) (SYM ±) (NN SEM))) (. .))) )
( (HEADING (NP (NN Table) (CD 1))) )
( (CAPTION (NP (NP (JJ Autoradiographic) (NN analysis)) (PP (IN of) (NP (NN GABAA) (NN receptor) (NN binding) (NNS sites))) (PP (IN in) (NP (NP (JJ horizontal) (NNS sections)) (PP (IN of) (NP (NML (NML (JJ wild) (NN type)) (CC and) (NML (NN mutant))) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NNS data)) (VP (VP (VBP are) (NP-PRD (NP (NP (NNS means)) (SYM ±) (NP (JJ standard) (NNS deviations))) (PP (IN for) (NP (NP (CD 5) (NNS mice)) (PP-LOC (IN in) (NP (DT each) (NN genotype))))))) (, ,) (CC and) (VP (VBP are) (VP (VP (VBN expressed) (NP-1 (-NONE- *)) (PP=2 (IN as) (NP (NP (NN nCi)) (PP (SYM /) (NP (NN mg))))) (PP=3 (IN for) (NP (CD 3H) (HYPH -) (NNS ligands)))) (CC and) (VP (PP=2 (IN as) (NP (NP (NN nCi)) (PP (SYM /) (NP (NN g))))) (PP=3 (IN for) (NP (NN 35S) (HYPH -) (NN ligand))))))) (. .))) )
( (CAPTION (FRAG (NP (NP (NN Significance)) (PP (IN of) (NP (NP (DT the) (NN difference)) (PP (IN from) (NP (JJ wild) (NN type))))) (PRN (-LRB- -LRB-) (NP (NP (NML (NNP Tukey) (HYPH -) (NNP Kramer)) (NN test)) (PP-TMP (IN after) (NP (NN ANOVA)))) (-RRB- -RRB-))) (: :) (S (S-FRM (NP-SBJ (NN aP)) (VP (SYM <) (NP (CD 0.05)))) (, ,) (S-FRM (NP-SBJ (NN bP)) (VP (SYM <) (NP (CD 0.01)))) (, ,) (S-FRM (NP-SBJ (NN cP)) (VP (SYM <) (NP (CD 0.001))))) (. .))) )
( (CAPTION (NP (NP (NP (NN Ctx)) (, ,) (NP (NN cortex))) (: ;) (NP (NP (NN Th)) (, ,) (NP (NN thalamus))) (: ;) (NP (NP (NN Hi)) (, ,) (NP (NN hippocampus))) (: ;) (NP (NP (NN CPu)) (, ,) (NP (JJ caudate) (NN putamen))) (: ;) (NP (NP (NN IC)) (, ,) (NP (JJ inferior) (NN colliculus))) (: ;) (NP (NP (NN Gr)) (, ,) (NP (JJ cerebellar) (NN granule) (NN cell) (NN layer))) (: ;) (NP (NP (NN Mol)) (, ,) (NP (JJ cerebellar) (JJ molecular) (NN layer))) (. .))) )
